The Global Drug Economy: Prohibition, Profiteering, and Failed States

On September 1, 2024, Oregon officially ended Measure 110, the boldest drug policy experiment in the United States, which had decriminalized the possession of all drugs four years ago. Now, the possession of heroin, cocaine, and methamphetamine has once again been criminalized. The transition from "pioneer" to "retreat" took only four years.

In the same week, 3,000 miles away in Washington, the CDC released a set of data that received almost no attention: the number of overdose deaths in the United States showed its first decline in years.

The policy correlation between the withdrawal of a policy deemed a "failure" and the improvement of a "success" indicator is extremely complex.

Humanity has spent 55 years and invested over a trillion dollars fighting drugs, yet the results are an increase in the number of drug users, improved drug purity, falling prices, and rising death tolls. If this were a corporation, the CEO would have been fired fifty years ago.

The root cause of a trillion dollars resulting in more deaths lies in the fact that the underlying logic of the War on Drugs has instead created the very problems it sought to solve. Every escalation in law enforcement opens up market space for the next generation of more lethal drugs; economics and neuroscience have joined forces to defeat the law.

Punishment mechanisms assume that individuals possess rationality, but the brains of addicts have long been reshaped by drugs, losing the capacity for rational decision-making. The scarcity brought by prohibition drives up profits, attracting more powerful suppliers, leading to record-high seizures year after year while street prices continue to drop. In the contest between law enforcement agencies and economic laws, there is almost no chance of winning.

To dismantle the mechanism of failure, one must approach it from three aspects. On the supply side, the drug trade has shifted from agriculture to chemistry, expanded from physical entities to the dark web, and spread from regional to global networks. Every "victory" achieved by law enforcement accelerates this evolution; taking down one node causes the network to automatically reorganize, and eliminating one substance allows a more lethal substitute to take its place. On the demand side, the neurological mechanisms of addiction, the socio-economic roots of despair, and the customer base for illegal markets created by pharmaceutical companies through legal channels collectively demonstrate that demand does not disappear due to punishment; it only moves into a more dangerous underground. At the policy level, from the death penalty in Singapore to medical heroin in Switzerland, and from Oregon's retreat to Portugal's persistence, global policy laboratories provide a rich set of control groups. Data indicates that once policy goals shift from eradicating drugs to reducing deaths, the death toll truly begins to decline.

The War on Drugs will not end with a proclamation; no president will stand at a podium and announce, "The war is over, prohibition has failed." Its end is destined to be gradual, fragmented, and full of reversals. Meanwhile, laboratories have already synthesized a new generation of compounds dozens of times stronger than fentanyl; the evolution of synthetic drugs is consistently faster than regulation. Humanity does not have another 55 years to squander.

A Trillion-Dollar Failure

In 1994, John Ehrlichman, former domestic policy advisor to Nixon, left a chilling confession during an interview with Harper's Magazine. The 1968 White House had two enemies: the anti-war left and Black people. They couldn't make it illegal to be against the war or to be Black, but they could get the public to associate hippies with marijuana and Black people with heroin, and then criminalize both heavily to disrupt those communities. They could arrest their leaders, raid their homes, and demonize them on the nightly news. Ehrlichman admitted: "Did we know we were lying? Of course we did."

This confession explains why the War on Drugs has failed on a data level yet persisted for 55 years on a political level. The War on Drugs was never designed as a public health policy, but as a set of tools for social control.

Lessons from Prohibition

When comparing the War on Drugs with the Prohibition of the 1920s, the differences are particularly glaring.

In 1920, the Eighteenth Amendment to the U.S. Constitution took effect, completely banning the production, sale, and transport of alcohol. Supporters believed this would purify society, reduce crime, and elevate morality, but the reality was exactly the opposite.

Prohibition gave birth to criminal empires like that of Al Capone. The number of speakeasies in Chicago grew from 15,000 before the ban to over 20,000 during it. Bootleg liquor, lacking quality control, led to methanol poisoning, blinding or killing thousands. The federal government lost $500 million in tax revenue annually while spending hundreds of millions more on enforcement.

In 1933, faced with the rise of organized crime and the loss of tax revenue, the U.S. government admitted failure and repealed Prohibition via the Twenty-first Amendment, lasting a total of 13 years.

The War on Drugs has been implemented for 55 years. Faced with the same organized crime (evolving from Al Capone to El Chapo) and even more dangerous substitutes (evolving from bootleg liquor to fentanyl), the machine continues to run.

The difference lies not in policy effectiveness—both created black market windfalls. The difference lies in the consumer profile: alcohol was a consumer product for mainstream voters, while heroin was a narcotic for marginalized groups.

The Balloon Effect

The aforementioned political inertia led to the famous "Balloon Effect."

In the 1980s, the United States launched a fierce crackdown on coca cultivation in Colombia. Satellite monitoring, aerial herbicide spraying, and military aid did indeed cause coca cultivation in Colombia to drop, but simultaneously, production in Peru and Bolivia immediately expanded to fill the market void.

In the 1990s, Caribbean smuggling routes were cut off, and Miami was no longer the primary entry point for cocaine. Mexican cartels immediately monopolized the market, with Sinaloa and Juárez becoming the new drug hubs.

In the 2010s, prescription opioids were strictly restricted, and OxyContin was no longer prescribed like candy. Demand for heroin immediately surged, prices fell, and purity rose.

In the 2020s, after heroin was targeted, fentanyl immediately filled the vacuum. The profit from one kilogram of fentanyl is ten times that of heroin, yet its volume is only one percent.

Every "tactical victory" at the enforcement level has spawned more covert routes, more brutal organizations, and more lethal compounds. This is not just a game of Whac-A-Mole; it is a process of selecting for superbugs.

Testimony of Numbers

Since Nixon declared the "War on Drugs" in 1971, the U.S. Treasury has invested over $1 trillion, flowing into the Drug Enforcement Administration (DEA), the prison system, and overseas military operations, constituting its direct costs.

The return on this investment is a baffling balance sheet:

• The global drug market size has expanded from approximately $10 billion in the 1970s to between $400 billion and $650 billion today.
• Street heroin purity has increased from less than 10% in the 1980s to over 50% today.
• Adjusted for inflation, cocaine prices have fallen by more than 80%.
• The U.S. incarcerated population has surged from 200,000 in 1970 to 2.2 million today, with 46% related to drug offenses.

The DEA's annual seizures break historical records every year, yet street prices for heroin and methamphetamine continue to fall year after year.

The collapse in prices due to oversupply is a manifestation of economic principles, not a failure of law enforcement.

Industrial Upgrading

Every round of "crackdowns" has inadvertently acted as a mechanism for survival of the fittest; clumsy drug traffickers are caught, while the shrewd ones become stronger.

Cartels learned to transport using submarines. Specialized shipyards have even emerged in the Colombian jungle to manufacture single-use semi-submersibles. Each costs $1 million to build and carries $100 million worth of cocaine. Even if intercepted by the Coast Guard, the crew simply opens valves to sink the evidence to the bottom of the sea.

Cartels learned to wash money using cryptocurrencies, utilizing Bitcoin mixers, Monero, and cross-chain bridges, making the tracking of fund flows as difficult as finding patterns at the level of quantum physics.

Cartels learned to manage supply chains like multinational corporations, including vertical integration, risk diversification, and brand management. The organizational chart of the Sinaloa Cartel is almost indistinguishable from a Fortune 500 company. Government crackdowns have objectively helped drug cartels complete their industrial upgrading.

The Paradox of the Kingpin Strategy

In 1993, when Colombian drug lord Pablo Escobar was shot dead, the world thought it was a victory. At his peak, Escobar controlled 80% of the global cocaine trade, earning $420 million a week. Killing such a figure should have dealt a heavy blow to the entire industry.

The reality was that the Medellín Cartel fragmented into dozens of small, flat, and hard-to-track criminal networks. A negotiable behemoth turned into countless untraceable ghosts; taking down a monopolist instead created countless competitors.

Between 2024 and 2025, the Mexican state of Sinaloa fell into a bloody civil war. The sons of El Chapo (Los Chapitos) broke with the faction of the cartel veteran El Mayo, leading to nearly 2,000 deaths. This is not just infighting between criminal groups, but direct evidence of the failure of the "Kingpin Strategy."

The CJNG (Jalisco New Generation Cartel) took the opportunity to rise, and by 2025, it became the first criminal group in history to cover all 32 states of Mexico, with its use of drones to drop explosives becoming commonplace.

Every "victory" makes the next one harder.

Political Function

Given such failure, why has the War on Drugs persisted for 55 years?

The answer lies in Ehrlichman's confession: the true function of the War on Drugs was never to eliminate drugs, but to provide a set of legitimate tools for social control.

Powers such as the right to arrest, search, and seize assets gained legitimacy under the banner of "anti-drug" efforts. Police can search vehicles that "smell like marijuana" without a warrant. Prosecutors can seize properties "suspected of drug trafficking," even if the owner is never convicted. The system of Civil Asset Forfeiture allows law enforcement agencies to seize property without a conviction. In 2014, the total value of assets seized by U.S. law enforcement through this system exceeded the total losses from burglaries for the first time.

The operation of this incarceration machine carries obvious racial selectivity. Black people are 3.73 times more likely to be arrested for drugs than white people, despite nearly identical usage rates between the two groups. This is not an enforcement bias, but a result of system design.

Prohibition was repealed after 13 years because alcohol consumers were the core electorate. The War on Drugs continues after 55 years because drug users are a marginalized group.

Whether a policy persists depends not on its effectiveness, but on who bears the cost.

Global Anti-Drug Budget

The United States is not the only country investing heavily in this war.

According to UNODC data, the global anti-drug budget has grown from approximately $100 million per year in the 1970s to over $35 billion today. This money flows into militarized border patrols, transnational law enforcement cooperation, prison expansion, and alternative crop projects.

However, the results are unsatisfactory. The size of the global illegal drug market exceeds one-tenth of the global oil trade and is comparable in scale to the global arms trade.

The United Nations Office on Drugs and Crime (UNODC) releases the World Drug Report annually, documenting the progress of this war. The 2024 report shows: global cocaine production has reached record highs, synthetic drug production is growing exponentially, and the opioid crisis is spreading from North America to the rest of the world.

Fifty-five years of war have yielded a drug market that is larger, purer, and cheaper than when the war began.

If this were a corporation, the CEO would have been fired fifty years ago.

The Hijacked Brain

In 1954, James Olds and Peter Milner of McGill University implanted electrodes into the septum of a rat. When a lever was pressed, an electric current stimulated the brain's pleasure center. That rat pressed the lever 7,500 times within 12 hours, even forsaking food and water until its physical strength was exhausted.

This was the first time humans observed in a laboratory setting that once the pleasure circuits are manipulated, survival instincts can be overwhelmed.

Seventy years later, the global drug market still follows similar neurological principles while also embodying the cold logic of the Pareto Principle. Eighty percent of users are recreational: a small amount of cocaine at a weekend party, ecstasy at a music festival, or a joint after work. The lives of these individuals do not collapse due to drugs. The remaining 20%, however, are problematic addicts who contribute the vast majority of market profits. Understanding this 20% group is the key to understanding the entire drug economy.

The Hijacked Brain

Neuroscience research shows that long-term use of opioids or stimulants alters the brain's prefrontal cortex and nucleus accumbens. The dopamine system is reshaped, and the urge to "seek drugs" overrides the instinct for survival.

Brain scans of addicts are starkly different from those of ordinary people. The reward circuitry undergoes permanent changes; responses to natural pleasures (such as food, sex, and social interaction) are weakened, while the craving for drugs is magnified dozens of times. This change is an organic pathology rather than a lack of willpower. Addicts do not actively choose drugs; rather, because their brains have been reprogrammed by drugs, they lose the capacity to choose.

Deaths of Despair

The "brain disease" model explains the biological mechanisms of addiction but ignores a crucial question: why are addiction rates significantly higher in certain groups than in others?

The "Deaths of Despair" theory, proposed by Princeton University economists Angus Deaton and Anne Case, provides a more explanatory framework.

In the Rust Belt and Appalachia, the loss of manufacturing jobs, the disintegration of community structures, and the proliferation of opioids show a striking geographical overlap. The opioid overdose death rate in Ohio is three times that of California, and the number of prescription opioids per capita in West Virginia once reached over 50 doses per person per year. These phenomena are not randomly distributed.

When factories close, communities dissolve, and hope for the future is lost, opioids become the sole chemical consolation. This is not because people in these regions have weaker willpower, but because a desperate social environment creates more vulnerable individuals.

The famous "Rat Park" experiment also confirms this: in traditional experiments, rats confined in isolated cages would frantically consume morphine-laced water until death. However, in the "Rat Park" experiment, rats living in a rich social environment rejected the morphine water, or quickly gave it up even if they tried it. This suggests that environment determines vulnerability; loneliness and despair are the breeding grounds for addiction.

Demand-Side Inelasticity

For drug cartels, recreational users are not only low-profit but also lack stability. If prices rise by 10%, recreational users might reduce consumption or turn to other forms of entertainment; if health warnings appear in the news, they might pause their purchases.

Heavy addicts are entirely different. When prices rise, they do not reduce consumption; instead, they obtain funds through crime, such as burglary, robbery, or prostitution. Economists call this "demand inelasticity": regardless of how the price changes, the volume of consumption remains almost constant. This indicates that the direct consequence of law enforcement actions pushing up drug prices is often an increase in social crime rates.

New York in the 1980s is a classic case. After police intensified crackdowns, heroin prices rose, and burglary rates soared accordingly. Addicts needed more money to buy more expensive drugs, and the only way to obtain that money was through crime.

The paradox of drug enforcement is that the more "successfully" prices are driven up, the more innocent citizens become victims of crime.

Loyal Customers

Only those heavy addicts whose brain structures have already been altered are the ideal "loyal customers" for drug cartels.

This is also why fentanyl is so favored by traffickers: it is not only highly profitable but also extremely addictive, capable of rapidly converting recreational users into heavy users. A recreational user who tries fentanyl may become an addict requiring multiple injections a day within a few weeks.

From a business perspective, this is a perfect customer conversion model. Silicon Valley growth hackers might spend millions of dollars studying user retention, but fentanyl's retention rate puts any SaaS product to shame. However, from a public health perspective, it is a disaster.

The high potency of fentanyl leads to the rapid buildup of tolerance; users must constantly increase the dose to achieve the same effect, and the safety margin between a lethal dose and an effective dose is extremely narrow. Two milligrams of fentanyl can be lethal, yet a heavy user might require hundreds of milligrams a day—every injection is like playing Russian roulette.

The Limits of Willpower

This asymmetry determines the limitations of relying solely on "willpower" or "draconian laws" to suppress demand.

When a person's living environment is full of despair and their brain has been altered by chemicals, the deterrent power of criminal law is nearly zero. For a heavy addict, the pain of withdrawal is immediate and certain, while legal punishment is delayed and uncertain.

This also explains why addiction problems persist even in countries that implement the death penalty. Singapore executes drug traffickers, and its drug use rate is indeed low; however, former Philippine President Duterte launched extrajudicial killings, yet the supply of methamphetamine was never interrupted. Punishment may deter rational decision-makers, but the brains of addicts have lost the capacity for rational decision-making.

The Economics of Treatment

If punishment is ineffective, then treatment options deserve in-depth exploration. Methadone maintenance treatment is currently the most well-evidenced method for treating opioid addiction. By providing a long-acting, oral opioid, methadone can alleviate withdrawal symptoms and cravings, allowing addicts to gradually return to a normal life.

Data shows that for addicts receiving methadone treatment, crime rates drop by more than 60%, employment rates gradually recover, and HIV infection rates decrease accordingly.

The problem lies in access. In the United States, methadone can only be obtained at specialized clinics, requiring patients to travel there daily. For addicts living in rural areas with a lack of transportation, this is almost impossible to achieve.

Buprenorphine is another option that can be prescribed by general practitioners. Before 2023, American doctors needed a special license (X-waiver) to prescribe buprenorphine. Even after this restriction was lifted, doctors willing to prescribe it remain scarce, and the supply of treatment falls far short of demand.

The Roots of Social Issues

Addiction is a disease; this does not mean that individuals have no choice at all, but rather that the difficulty of making that choice is vastly underestimated.

A person living in a stable community with a job and family support has a much lower probability of becoming addicted, even if they try drugs, compared to someone who is unemployed, lonely, and living in a decaying neighborhood. As long as social structures continue to manufacture despair, no amount of law enforcement can stop people from seeking chemical numbing.

The opioid crisis in the Rust Belt is not a moral failure but a consequence of economic policy. When NAFTA moved manufacturing jobs to Mexico, when automation replaced assembly line workers, and when the economic foundation of entire communities collapsed within a generation, chemical consolation became the only way out.

The experience of Vietnam War veterans provides another perspective: in Vietnam, about 20% of US soldiers used heroin, and many were heavily addicted. The military originally expected these individuals to become a massive social problem upon returning home; however, the vast majority of veterans naturally stopped using after returning, often without any treatment. Once the environment changed, the addiction disappeared; once the fear and loneliness of the battlefield vanished, heroin lost its appeal. This case demonstrates that addiction is not just a matter of chemicals, but a matter of the living environment.

The War on Drugs attempts to use police to solve an economic problem, and 55 years of failure have proven that this path is non-viable.

Anatomy of the Supply Chain

In June 2019, U.S. Customs seized the container ship MSC Gayane at the Port of Philadelphia. Hidden on board were nearly 20 tons of cocaine with a street value exceeding $1.3 billion—the largest maritime seizure in U.S. history. The owner of the vessel was none other than JPMorgan Chase.

This shipment was just the tip of the iceberg. The DEA estimates border interception rates are below 10%, meaning for every ton seized, at least nine tons successfully flow into the market. Even more troubling for law enforcement is the emergence of fentanyl, which has changed the landscape, rendering bulk maritime smuggling increasingly obsolete.

From Farmland to Laboratories

In the past, producing one kilogram of heroin required one hectare of poppy fields and several months of time, including planting, harvesting, extraction, and refining. The entire process was constrained by season, weather, and geography. Afghan poppy fields could be monitored by satellites, and coca cultivation in Colombia could be destroyed by aerial herbicide spraying.

Today, producing one kilogram of fentanyl requires only a laboratory, a few technicians, and 48 hours.

Precursor chemicals are purchased from chemical plants in China or India, transported through normal international trade channels, synthesized in underground laboratories in Mexico, and the final product eventually crosses the border into the United States.

Cutting off an agricultural supply chain can take years, while rebuilding a dismantled fentanyl lab takes only 48 hours.

The supply chain has thus become difficult to sever because satellites cannot monitor reaction vessels in a basement.

Profit Distribution

The distribution of profits reveals the brutality of the industry: in cocaine with a street price of $1,000, farmers in the Andes receive less than $4. The remaining $996 is carved up by various links in the distribution chain: $4 for the coca farmer, $10 for local buyers, $50 for refining and processing, $200 for cross-border transport, $300 for wholesale distribution, and $436 for street retail.

This profit distribution structure is remarkably similar to that of an Apple iPhone; in the retail price of an iPhone, Chinese assembly workers receive less than 2%, while Apple Inc. takes 58% of the profit. The difference is that Apple's premium comes from brand and design, while the drug premium stems from risk and violence. Both confirm the economic law that value chain profits concentrate in the most difficult-to-replace segments.

The largest premium appears at the moment of crossing a national border. Risk equals value, and every border becomes a price multiplier.

This also explains why border enforcement cannot eradicate the drug trade: as long as there are borders, there is room for arbitrage; the stricter the enforcement, the higher the profit for a successful crossing, and the more people are willing to take the risk.

The profit structure of heroin is similar: the retail price of one kilogram of heroin is approximately $80,000, of which farmers in Afghanistan or Myanmar receive less than $1,000. Over 90% of the profits are concentrated in cross-border transport and wholesale segments.

The profit structure of fentanyl is even more extreme. The cost of precursor chemicals is extremely low and the synthesis process is simple, yet the street value of the finished product is comparable to heroin, resulting in profit margins that can reach thousands of times the cost.

Money Laundering Engineering

This cash must flow back into the financial system. The U.S. Treasury's Financial Crimes Enforcement Network (FinCEN) estimated in 2025 that the scale of money laundering by Chinese underground banks for Mexican drug cartels reached as high as $312 billion.

At this stage, it is no longer a simple matter of carrying cash in suitcases, but a complex Trade-Based Money Laundering (TBML) system.

The operation works as follows: drug proceeds are collected in the U.S. and deposited into accounts controlled by Chinese entities. These funds are used to purchase legitimate goods such as Chinese-made mobile phones, textiles, and electronics. The goods are exported to Mexico or other Latin American countries and liquidated in local markets. The liquidated funds are ultimately paid to the drug cartels in pesos or dollars.

In this system, money never actually flows across borders; it is simply offset on ledgers: the Chinese exporter receives payment for goods, the Mexican importer receives the goods, and the drug cartel receives clean cash.

The complexity of this financial engineering leaves traditional "Follow the Money" strategies almost powerless.

The connection between the Chinese financial system and the global drug trade is far deeper than officially acknowledged.

Narco-Submarines

In this ecosystem, specialized shipyards have even appeared in the jungles of Colombia to manufacture single-use semi-submersibles.

These "narco-submarines," approximately 20 meters long and made of fiberglass, sit only about 30 centimeters above the water's surface, making them nearly undetectable by radar. Each submarine, costing about $1 million to build, can carry $100 million worth of cocaine.

Even if intercepted by the Coast Guard, the crew simply opens valves to sink the evidence to the bottom of the ocean, thereby avoiding conviction.

For drug cartels, losing a submarine is like FedEx losing a package: annoying, but within the budget.

More advanced fully submersible unmanned underwater vehicles (UUVs) have already appeared, capable of crossing the Atlantic directly to European shores, achieving transport without a crew, without hostages, and without witnesses.

When one end of the supply chain is highly industrialized precursor production and the other is a decentralized global money laundering network, with unmanned vehicles in between, traditional border interception is like using a fishing net to catch nanobots.

Precursor Chemicals

The synthesis of fentanyl requires specific precursor chemicals, primarily N-Phenethyl-4-piperidone (NPP) and 4-Anilino-N-phenethylpiperidine (4-ANPP).

These chemicals are produced on a large scale in chemical plants in China and India, nominally for the legitimate pharmaceutical industry. In 2019, under U.S. pressure, China added fentanyl and its analogues to its controlled substances list.

However, the effectiveness of regulation is limited. The trade in precursor chemicals moved underground, and the practice of exporting finished fentanyl products shifted to exporting precursor chemicals and completing the final synthesis steps in Mexico. Chemicals on the regulatory list are replaced with substitutes that have slightly different structures but identical functions, thereby evading the scope of control.

This is a cat-and-mouse game between chemists and regulators. Scheduling a substance requires months or even years of legislative procedures, while adjusting a molecular structure takes only days.

The evolution of synthetic drugs is always faster than the regulatory lists.

Micro-Smuggling

The high potency-to-weight ratio of fentanyl has dramatically changed the logistics of smuggling.

Two milligrams of fentanyl can be lethal; one kilogram of fentanyl is enough to kill 500,000 people.

Smuggling has thus become micro-sized: trucks and containers are no longer needed; only standard mail and express parcels are required. The fentanyl in a standard envelope is enough to supply the weekend demand of a medium-sized city.

The U.S. Postal Service processes hundreds of millions of pieces of mail every day, and Customs cannot inspect them one by one. Even with X-ray machines and drug-sniffing dogs, the rate of items slipping through remains extremely high.

When drugs can be delivered to the door like an Amazon package, a border wall becomes an expensive political symbol rather than an effective law enforcement tool.

Darknet Logistics

The internet has added a new dimension to drug trafficking: on darknet markets, buyers can browse products, compare prices, and read reviews just like on e-commerce platforms. Sellers provide detailed product descriptions, purity guarantees, and even after-sales service. Transactions are paid for with Bitcoin or Monero, and shipping relies on the regular postal system.

This model eliminates the risk of violence associated with street transactions. Buyers do not need to walk into dangerous neighborhoods, and sellers do not need to hire armed bodyguards. Both parties to the transaction are hidden behind the protection of encryption technology.

After law enforcement shuts down one darknet market, three replacements spring up within 48 hours. New markets often learn from the security vulnerabilities of their predecessors, becoming even harder to penetrate.

After the Silk Road was shut down, the volume of drug transactions on the darknet did not decrease but increased. Law enforcement actions instead became a selection mechanism, weeding out the weak and leaving behind more covert survivors.

Resilience of the Supply Chain

Traditional supply chains have obvious bottlenecks: poppy fields can be destroyed, refineries can be raided, and transport ships can be intercepted.

The supply chain for synthetic drugs has almost no bottlenecks. Precursor chemicals come from thousands of legitimate chemical plants, synthesis can be completed anywhere with basic equipment, and distribution is carried out through decentralized networks.

If one node is taken down, the network automatically reroutes because the supply chain structure is a mesh, not linear.

The DEA's annual seizure volumes hit record highs, yet street prices continue to fall year after year. The answer to this paradox lies in the supply chain structure: when supply is distributed, redundant, and replaceable, any single-point strike is unlikely to affect overall output.

The drug supply chain has become an anti-fragile system; the greater the pressure, the faster it adapts.

The evolutionary trajectory of this supply chain precisely replicates the core paradox of the War on Drugs. Economics provides the drive: the excess profits created by prohibition are sufficient to drive any technological innovation. Neuroscience locks in the demand: the brains of addicts do not stop craving because the supply chain is hit. The result of these two forces merging is that every round of law enforcement upgrades filters for more efficient, more covert, and more lethal forms of supply. From poppy fields to underground labs, from containers to standard mail, from heroin to fentanyl, every "forced upgrade" of the supply chain is another verdict of law losing to economics.

Narco-States

In 1993, the killing of Colombian drug lord Pablo Escobar was hailed as a monumental victory.

At his peak, Escobar controlled 80% of the global cocaine trade, earning $420 million a week, and his net worth once placed him on the Forbes list of the world's wealthiest people. Eliminating such a figure should, in theory, have dealt a devastating blow to the entire industry.

Instead, the Medellín Cartel splintered into dozens of smaller groups, transforming from a negotiable behemoth into countless untraceable ghosts.

The cruel paradox lies here: taking down a kingpin often makes the problem harder to solve.

The Failure of the Kingpin Strategy

The "Kingpin Strategy" has been the core tactic of the U.S. War on Drugs: identifying and eliminating the leaders of drug trafficking organizations in the hope that the organizations will subsequently collapse.

In theory, this makes sense because criminal organizations rely on the leader's personal network, decision-making abilities, and deterrent power; removing the leader should plunge the organization into chaos.

In reality, every "success" has brought worse consequences: after Escobar's death, the Medellín Cartel's market share was taken over by the Cali Cartel; after the Cali Cartel was dismantled, Mexican cartels rose to power; and as their leaders were arrested or killed, these organizations splintered, leading to an escalation of violence.

In 2024, when the sons of the legendary leader of the Sinaloa Cartel, "El Chapo," fell into infighting, the state of Sinaloa turned into a war zone. The break between "Los Chapitos" and the faction of the cartel veteran "El Mayo" resulted in nearly 2,000 deaths. When a monopoly is destroyed, what follows is a power vacuum and a violent struggle for control.

The Rise of the CJNG

The CJNG (Jalisco New Generation Cartel) seized the opportunity to rise, and by 2025, it became the first criminal group in history to cover all 32 states of Mexico.

The level of violence employed by this organization far exceeds that of its predecessors. Explosives dropped from drones have become commonplace, armored vehicles engage in firefights with military and police on highways, and entire towns are sometimes blockaded, forcing residents to flee.

The founder of the CJNG, Nemesio Oseguera Cervantes (nicknamed "El Mencho"), was once a member of the Sinaloa Cartel. He built his empire as the older cartels weakened due to internal strife.

This is the ironic conclusion of the Kingpin Strategy: by eliminating old monopolists, it cultivates new, more brutal competitors.

The Afghanistan Paradox

On the other side of the globe, Afghanistan provides another extreme case. In 2023, the Taliban issued a drug ban, reducing poppy production by 95% within a single year. This was something the United States failed to achieve over 20 years and billions of dollars, yet the Taliban succeeded.

The method was simple: any farmer caught growing poppies would be arrested, their land confiscated, and their family punished. There were no legal procedures, no channels for appeal, and no way for human rights organizations to intervene.

The cost was that millions of farmers lost their only source of income. Poppies are the backbone of Afghanistan's rural economy, and many families depend entirely on poppy income for survival. Consequently, the ban led to a severe humanitarian crisis and famine. Herein lies the ultimate paradox of prohibition: a ban can "succeed," but the price of that success is more than society can bear.

The Taliban's "success" is a reductio ad absurdum of the logic of prohibition. If eliminating drugs requires totalitarian rule and humanitarian disaster, then the goal itself becomes questionable.

Syria: A Narco-State

Meanwhile, Syria has transformed into a total narco-state. The annual production value of Captagon (a type of fenethylline, an amphetamine-based stimulant) exceeds $5 billion, surpassing the total of all the country's legal exports. The Assad regime not only tolerates but directly participates in production and smuggling, using drug money to sustain its crumbling rule.

The primary markets for Captagon are Saudi Arabia and the Gulf states. Ironically, these countries, which impose harsh Islamic legal penalties for drugs, are the largest consumers of Captagon.

The Syrian case demonstrates how drugs can become a survival strategy for sanctioned nations. When the legal economy is destroyed by international sanctions, the illicit economy becomes the only source of foreign exchange.

North Korea, Venezuela, and the Myanmar military junta have all slid down similar paths. Drugs are not just a crime; they are a tool of geopolitics.

The Fall of Ecuador

Ecuador was once one of the safest countries in South America, but in 2024, it turned into a war zone.

The reason is simple: its geographical location is advantageous, situated between Colombia and Peru, the world's two largest cocaine producers. As Mexican cartels sought new transport routes, Ecuador's ports became ideal springboards.

The Albanian mafia, Mexican cartels, and remnants of Colombian armed groups fight for territory in Ecuador's prisons and streets. In January 2024, gunmen stormed a television studio during a live broadcast, taking the host hostage. The president declared an "internal armed conflict," and the military was deployed to the streets.

The drug trade flows like mercury; wherever there is a governance vacuum, that becomes the next hub. The tragedy of Ecuador proves that no country can remain isolated from the issue.

The Revival of the Golden Triangle

The Golden Triangle region of Myanmar is experiencing explosive growth in synthetic drug production. Following the 2021 military coup, the central government's control over border regions further weakened. Ethnic armed groups and criminal organizations filled the power vacuum, leading to an exponential increase in methamphetamine (ice) production and a collapse in prices.

A 2025 United Nations report shows that the Golden Triangle has surpassed Latin America to become the world's largest center for synthetic drug production. The wholesale price of methamphetamine tablets has dropped to less than $1 per pill, causing these drugs to flood Southeast Asia and Oceania.

Unlike the cocaine trade in Latin America, synthetic drug production in the Golden Triangle operates almost entirely outside of state control. There is no negotiable government, no arrestable leaders, and no farmland that can be sprayed with herbicides.

This is the future of the drug trade: decentralized, synthetic, and difficult to track.

The Curse of Failed States

The drug trade and state failure form a vicious cycle: weak governments cannot control their territory, and criminal groups fill the vacuum; the violence and corruption of these criminal groups further weaken government capacity, creating a cycle where the weaker the government, the stronger the criminal groups.

The commonality among countries like Mexico, Colombia, Afghanistan, Myanmar, Syria, and Ecuador is not culture or religion, but a lack of governance capacity.

This is strikingly similar to the logic of the "resource curse," where oil-rich nations like Nigeria, Venezuela, and Angola fall into cycles of corruption, violence, and governance collapse. The difference is that oil is legal while drugs are illegal, but the result is the same: drug revenues flow into weak governments, corroding institutions and dismantling society. Drugs are another form of the resource curse, only the source of the curse is the windfall profits created by prohibition.

Proponents of the War on Drugs believe that strengthening law enforcement can defeat criminal groups, but the reality is that law enforcement itself requires an effective state apparatus. In places where the state apparatus has already been corroded or dismantled, more law enforcement only brings more violence.

Taking down one drug lord often creates ten competitors; destroying one cartel may trigger a civil war. This is not the solution; it is the problem itself.

The Penetration of Corruption

The scale of drug profits makes corruption almost inevitable. The case of Mexico is the most shocking: during El Chapo's trial in New York in 2019, a witness testified that former President Peña Nieto had accepted a $100 million bribe. Although the Mexican government denied it, no one was surprised.

In Colombia, Pablo Escobar once offered to pay off the country's entire foreign debt on the condition that he not be extradited to the United States. In Afghanistan, government officials backed by the U.S. were simultaneously receiving salaries from the CIA and drug cartels. In Myanmar, military generals are directly involved in methamphetamine production.

When the annual income of criminal groups exceeds the GDP of many countries, corruption is no longer a moral issue for individual officials, but a profound structural problem.

A police officer's monthly salary is $500, while the reward for letting a shipment pass is $5,000. A judge's annual salary is $30,000, while the reward for a "not guilty" verdict is $300,000. Under such economic incentives, expecting integrity is naive because the budget for anti-corruption can never exceed the budget for corruption. This is arithmetic, not morality. The War on Drugs has not only failed to eliminate crime but has instead embedded the tentacles of crime deep within the state apparatus.

The Economics of Violence

Why is the drug trade so violent? The answer lies in the absence of property rights: in legal markets, commercial disputes can be resolved through courts, but in illegal markets, the only mechanism for arbitration is violence.

One drug dealer cannot sue another for breach of contract, nor can a cartel apply for trademark protection. When a competitor encroaches on territory, the only response is force.

This explains why the level of violence in the drug trade far exceeds that of other illegal industries. The profits from smuggling cigarettes or pirated software are also high, but they are rarely accompanied by large-scale massacres. The difference is that the profit margins in the drug market are high enough to make killing worthwhile.

Mexico's homicide rate is negatively correlated with drug prices: when prices fall and profit margins narrow, competition between cartels intensifies, and violence escalates. Prohibition creates windfall profits, and windfall profits in turn generate violence—it is a closed loop.

This loop reveals the deeper failure mechanism of the War on Drugs. Economics determines the scale of windfall profits; the stricter the prohibition, the higher the profits. The intensity of violence rises in tandem with profits, and the organizations that survive are inevitably more brutal and better at adapting. Meanwhile, neuroscience locks in the demand side; an addict's brain will not stop craving just because a cartel changed its name. Every time law enforcement eliminates an old organization, it clears the field for a more vicious successor; every time an old route is shut down, it forces smugglers to develop more hidden channels and more efficient synthetics. From Escobar to the CJNG, from heroin to fentanyl, the escalation of violence and the evolution of drugs are two sides of the same coin.

The Fentanyl War

In 1839, Britain used gunboats to force the Qing government to accept the opium trade in order to reverse its trade deficit with China. 185 years later, fentanyl precursor chemicals flow from China to Mexico, are synthesized and then surge into the United States, with the drug proceeds laundered back through Chinese underground banks.

Beyond the fact that history rhymes, there is a certain sense of cold symmetry.

The Three-Country Supply Chain

This symmetry is by no means simple "revenge"; it is an inevitable product of the globalized division of labor.

China possesses the world's most complete chemical supply chain. Thousands of chemical plants produce various fine chemicals, many of which can serve as precursors for fentanyl. The situation in India is similar. These chemicals are nominally intended for the legitimate pharmaceutical industry, and their export is entirely legal. Mexico possesses the most sophisticated smuggling networks; decades of cocaine and heroin trade have cultivated professional logistical capabilities: tunnels, submarines, drones, and corrupt border officials. The United States sits on the largest market for opioid consumption. Aggressive marketing of OxyContin sparked the first wave of addiction; after prescription drugs were restricted, the addicted population turned to the streets.

Three countries, three comparative advantages, piecing together a perfect supply chain. If an economics textbook needed a counter-example of "comparative advantage," the fentanyl trade would be an excellent candidate.

In 2023, approximately 110,000 people in the United States died from drug overdoses, more than 70% of which were related to fentanyl. This figure eclipses the combined total of deaths from car accidents and shootings. Mortality rates in Appalachia, the Rust Belt, and rural areas are far higher than in major coastal cities, sharing common characteristics of economic decline, community disintegration, and a lack of medical resources. Initially, fentanyl primarily affected middle-aged white men—the legacy addicts of the OxyContin era. Today, counterfeit prescription pills are rampant among teenagers. An 18-year-old might think they are swallowing a Xanax to relieve anxiety, but they are actually ingesting a lethal dose of fentanyl. The downward shift in age distribution indicates that fentanyl has moved beyond the scope of a "legacy issue" and evolved into an entirely new crisis.

The 2mg Perfect Weapon

The root of fentanyl's disruption of the entire drug trade's logistics lies in a single number: 2 milligrams can be lethal, equivalent to only a few grains of salt. One kilogram of fentanyl is theoretically enough to kill 500,000 people.

Its potency is 50 to 100 times that of heroin. Achieving the same "high" requires an extremely small amount of the substance. For smugglers, the powder in a standard envelope is enough to supply the weekend needs of a medium-sized city.

This extreme potency-to-weight ratio has reshaped smuggling logistics. Traditional drug smuggling relies on trucks, containers, and even submarines; fentanyl has no such limitations. A kilogram is only about the size of a book but is worth millions of dollars. Ordinary mail, express parcels, and trace amounts of powder tucked inside legitimate goods can all complete the transit. The U.S. Postal Service processes hundreds of millions of pieces of mail every day, and Customs lacks the capacity to inspect them one by one. Even with X-ray machines and drug-sniffing dogs, the rate of evasion remains extremely high. Fentanyl detection relies on specialized equipment and trained personnel, which most ports of entry do not possess.

When drugs can be delivered to the door like an Amazon package, a border wall becomes nothing more than an expensive political prop.

For users, this same characteristic is a death knell. The purity of street drugs fluctuates wildly; the fentanyl content in one batch may be ten times that of another. Even more dangerous is that fentanyl is frequently laced into other drugs. Cocaine, methamphetamine, and counterfeit prescription pills may all hide lethal doses. Buyers often do not even know what they have ingested. Every injection is like a game of Russian roulette.

Beijing's Ledger

The mutual finger-pointing between the Chinese and U.S. governments over the fentanyl issue is like a carefully choreographed political performance. U.S. officials accuse China of lax regulation over the export of precursor chemicals. Chinese officials counter that the root of the problem lies in the United States' own demand.

The reality is more awkward than either narrative suggests.

China's chemical production capacity ranks first in the world, with thousands of small chemical plants operating outside the regulatory system. In 2019, under U.S. pressure, China added fentanyl and its analogues to its controlled substances list. The channels for exporting finished products were indeed hit. They were replaced by the trade in precursor chemicals—produced legally in China, exported to Mexico, and undergoing the final step of synthesis there. Chemicals on the regulatory list are replaced by substitutes with slightly different structures that function identically but fall outside the scope of control. Chemists only need to adjust the position of a few atoms to bypass the law.

Beijing's true stance is hard to describe as "inability to regulate"; rather, it views precursor control as geopolitical leverage. When China-U.S. relations are tense, cooperation freezes; when there is an urgent need for de-escalation, a few rounds of joint law enforcement are offered as a signal of goodwill. The resumption of fentanyl cooperation after the 2023 San Francisco summit coincided exactly with the window of time in which the Chinese side hoped to stabilize bilateral relations. The intensity of regulation over precursor chemicals serves, in the end, as a diplomatic thermometer, not a public health tool. The Opium War Museum receives millions of visitors every year; this historical memory means that any "concession" by Beijing on the fentanyl issue requires domestic political cover.

Purdue Pharma's aggressive marketing created the U.S. opioid market, and Chinese chemical plants are responsible for filling that appetite. The Sackler family paid $7.4 billion to settle criminal liability, yet no one is held responsible for the subsequent evolution of this market. A more difficult problem is that precursor chemicals have broad legitimate uses; blindly banning their production and trade would inevitably impact the entire pharmaceutical industry. Drawing a clear line between legitimate demand and illegal abuse is nearly impossible.

The Chemical Arms Race

Every round of regulation gives rise to more lethal alternatives.

Nitazenes are 20 to 43 times more potent than fentanyl. In 2025, the DEA reported that these substances had been detected in all 50 U.S. states. Some Nitazene variants are resistant to naloxone, which is currently the primary antidote used to save the lives of those who overdose. If the antidote fails, the overdose death rate is bound to climb sharply. Carfentanil, originally used to tranquilize elephants and 100 times more potent than fentanyl, has now appeared in street samples. An anesthetic designed for a 2-ton mammal is being pushed into the veins of a 70-kilogram human.

Scheduling a substance takes months or even years of legislative procedures. Adjusting a molecular structure takes only a few days. Underground chemists are always one step ahead. This situation is identical to the logic of the Cold War nuclear arms race: the U.S. deploys anti-missile systems, and the Soviet Union develops multi-warhead missiles; the DEA schedules fentanyl, and underground chemists synthesize Nitazenes. The lesson of the arms race is timeless: in a technological confrontation, the defender is destined to be at a disadvantage.

The amount of fentanyl seized by the DEA reaches new highs every year, yet street prices continue to fall because supply far exceeds interception capabilities. Border interceptions only capture a small fraction of the total smuggled volume; rising seizure amounts precisely confirm that the inflow is even larger. Arresting drug dealers is similarly ineffective; fentanyl production and distribution are highly decentralized—take down one network, and another immediately fills the void. International cooperation faces political obstacles; tensions in China-U.S. relations cause joint law enforcement to be intermittent, and even when both sides are willing, coordination at the executive level is full of challenges. When the supply chain becomes microscopic, decentralized, and globalized, traditional law enforcement methods are like using a fishing net to catch sand.

The Next Generation of Threats

Fentanyl may only be the beginning.

Advances in synthetic biology are making it increasingly easy to produce opioids in a laboratory. Theoretically, genetically modified yeast could ferment morphine or its analogues. The technology is not yet fully mature, but progress is rapid. Once it matures, anyone could produce opioids in their own kitchen, rendering poppy fields, chemical plants, or cross-border smuggling obsolete. Physical barriers to controlling the flow of substances will become useless.

AI-assisted drug design has opened another accelerated path. Machine learning algorithms can predict the relationship between molecular structure and pharmacological activity, accelerating the development of new synthetic drugs. Underground chemists may soon be able to use these tools to design molecules that have not yet been scheduled. As Nitazenes and even more potent synthetics are born in laboratories, the window of time for policymakers to adjust their strategies is narrowing sharply.

Fifty-five years ago, Nixon declared war on the poppy. Today's opponent has been replaced by a line of molecular formulas and a fermentation tank. The object of the war has long since crossed the boundaries of the plant kingdom and evolved into code, yet Pentagon-style anti-drug budgets are still chasing the remnants of the last war. In a chemical arms race, law enforcement is forever struggling to keep up. The only way out may be to break away from the mold of severe crackdowns and instead fundamentally re-examine the relationship between humans and psychoactive substances.

The Cannabis Shift

In 2022, Thailand became the first country in Asia to legalize cannabis. Within a short period, thousands of cannabis shops emerged on the streets of Bangkok, attracting a massive influx of tourists, with media dubbing it the "Amsterdam of Asia."

In 2025, the Thai government announced that cannabis would be re-listed as a narcotic, restricted solely to medical use.

The transition from "Asian Pioneer" to a "policy U-turn" took only three years.

The Collapse of the Thai Experiment

Thailand's legalization of cannabis was not based on liberal ideology but rather on economic considerations.

The COVID-19 pandemic dealt a heavy blow to Thailand's tourism industry, and the government hoped to fill this gap through cannabis tourism. In June 2022, Thailand removed cannabis from its list of narcotics, becoming the first country in Asia to do so.

The problem lay in the fact that the pace of legalization far outstripped the development of a regulatory framework. Cannabis shops proliferated without licenses; products lacked quality standards, THC content labeling, or age restrictions; and they were easily accessible even near schools.

Conservative political forces quickly retaliated. Buddhist groups, parent organizations, and opposition parties formed a coalition to exert pressure, prompting the new government after the 2024 general election to pledge to "correct the mistake" and re-list cannabis as a controlled substance in 2025.

The Thai case demonstrates that legalization is not an irreversible one-way process; legalization without supporting regulations can bring about problems more severe than those under a ban.

Uruguay's Decade

In sharp contrast to Thailand is Uruguay. In 2013, Uruguay became the first country in the world to fully legalize cannabis. Ten years later, this small South American nation has delivered a steady performance.

As the black market share gradually shrinks, the price of cannabis through legal channels has reached parity with the black market while offering guaranteed quality, leaving consumers with no reason to risk purchasing products of unknown origin.

Although critics once predicted that legalization would lead to a surge in youth consumption rates, data shows that these fears did not materialize, as youth usage rates have remained stable throughout.

Society did not collapse as a result, nor was there a so-called moral decline, a spike in crime, or a public health crisis. Uruguay remains one of the most stable and safest countries in South America.

The key to Uruguay's success lies in incremental implementation. The government spent years establishing a regulatory framework, ensuring that the pharmacy system, cultivation licenses, and quality standards were in place before legalization occurred.

The Federal Dilemma in the United States

Cannabis policy in the United States presents a unique state of fragmentation: at the federal level, cannabis remains listed as a Schedule I controlled substance, on par with heroin; meanwhile, at the state level, as of 2025, 24 states have legalized recreational cannabis, and 38 states allow medical cannabis.

The conflict between federal and state laws has given rise to a gray industry worth tens of billions of dollars.

Because federal law prohibits banks from providing services for drug transactions, cannabis businesses in legal states cannot use the banking system and must rely on cash transactions, making them targets for robbery.

Interstate transportation is considered a federal felony, which prevents legal cannabis in California from being sold in Nevada—even though it is legal there as well—resulting in each state becoming an isolated market.

Tax policies also disadvantage legal enterprises. Section 280E of the federal tax code prohibits drug traffickers from deducting normal business expenses, leading to effective tax rates for legal cannabis businesses that can reach as high as 70%.

This regulatory environment often keeps the price of legal cannabis higher than that of the black market. The rampant illegal plantations in California indicate that legalization has not eliminated the black market but rather coexists with it.

Germany's Cautious Attempt

In 2024, Germany became the largest EU country to legalize cannabis, but it adopted a more conservative model than the Netherlands: individuals can possess 25 grams of cannabis and grow three plants at home, while commercial sales remain strictly restricted, conducted only through non-profit "cannabis clubs."

Evaluations from the first year show a slight decrease in crime rates, and public health indicators have not worsened. Germany's cautious stance has deep-seated reasons: as a core member of the EU, overly aggressive legalization could trigger backlash from neighboring countries or conflict with the EU's drug policy framework.

Germany chose a middle path: acknowledging the failure of prohibition while avoiding the risks that full commercialization might bring.

The Dutch Paradox

The Dutch "coffee shop" model has operated for nearly 50 years, but it has never truly achieved legalization.

In the Netherlands, selling cannabis is illegal while purchasing it is legal. This status quo means that coffee shops can sell cannabis to customers but cannot legally restock their inventory, a phenomenon known as the "backdoor problem."

This semi-legal state has created an absurd situation: the suppliers for coffee shops are criminal organizations, and while the government taxes the retail end, it turns a blind eye to the supply end.

In 2025, the Netherlands finally began piloting a "closed supply chain" project, allowing specific growers to legally supply coffee shops in an attempt to fix this policy loophole after 50 years.

The Dutch experience suggests that halfway reforms can be worse than either a ban or full legalization, as gray areas easily breed corruption and crime.

Singapore's Other Extreme

At the other end of the policy spectrum, Singapore maintains an extremely harsh stance toward cannabis. Carrying more than 500 grams of cannabis can result in the death penalty, and even possession of small amounts can lead to long-term imprisonment and mandatory drug rehabilitation.

Singapore's draconian laws have indeed produced a powerful deterrent effect, with drug use rates consistently maintained at extremely low levels. However, such a model comes with a corresponding price.

Singapore's success relies on specific conditions such as being a small nation, having a strong government, highly controlled borders, and a cultural tradition of obedience to authority—conditions that do not exist in most countries.

A deeper question is whether this "success" is worth it: is it reasonable to employ the state's machinery of violence and deprive citizens of personal liberty or even life for a relatively mild substance?

Different societies will have different answers.

Global Fragmentation

The global landscape of cannabis policy is a fragmented puzzle: in Colorado, cannabis can be purchased in stores like beer; in Singapore, the same act can lead to the death penalty; in the Netherlands, selling is illegal while buying is legal; in Thailand, policy underwent a 180-degree turn within three years.

This fragmentation reflects a profound divergence in how human society perceives this plant.

Is cannabis ultimately a dangerous drug or a mild recreation? Is it a "gateway" to harder drugs or a safer alternative to alcohol? Is it a social cancer that needs to be eradicated or a manageable adult choice?

Scientific evidence does not support extreme positions: cannabis is indeed addictive, affects youth brain development, and increases the risk of certain mental illnesses; however, it is also safer than alcohol and tobacco, possesses medical value, and does not lead to overdose deaths.

Policy choices are ultimately value judgments, not scientific conclusions.

Taxes and the Black Market

Proponents of legalization often emphasize tax revenues. As of 2023, cumulative cannabis tax revenue in legal U.S. states reached $24.7 billion.

However, this figure masks an awkward reality: high tax rates are driving consumers back to the black market.

Cannabis tax rates in California can be as high as 40%, making prices in legal shops double those of the black market. For price-sensitive consumers, the choice is obvious.

After legalization in California, illegal plantations actually increased. These plantations are typically operated by transnational criminal organizations, use illegal immigrant labor, and cause severe environmental damage.

Legalization does not automatically eliminate the black market. If tax rates are too high and regulations too strict, the legal market will lose to the cheaper illegal market.

Oregon reduced its cannabis tax rate from 17% to 10% in 2023 in an attempt to compete with the black market; the effectiveness of this move remains to be seen.

The Blurred Boundary Between Medical and Recreational

Cannabis legalization usually begins with medical use, a foundation that is well-established: it can alleviate nausea caused by chemotherapy, reduce chronic pain, and help certain epilepsy patients. The FDA has also approved several cannabinoid drugs.

The problem is that medical cannabis programs often become a backdoor for recreational use. In many states, obtaining a medical cannabis card is very easy; "chronic pain," as a subjective symptom that is difficult to verify, can always find a doctor willing to write a prescription, making medical cannabis programs effectively quasi-legalization.

This ambiguity serves a specific political function because "medical use" gains public support more easily than "recreational use." Recreational legalization in many states began precisely with medical programs.

A more honest approach would be to acknowledge that the primary purpose for most medical cannabis users is recreation. If society decides to allow adults to use cannabis, it should legalize it directly rather than through the backdoor of the medical system.

The Future of Cannabis

The trend toward cannabis legalization seems unstoppable. More than 50 countries or regions worldwide have achieved some form of legalization or decriminalization. The United Nations removed it from its most restrictive category of control in 2020, and the younger generation's attitude toward cannabis is far more tolerant than that of their parents.

Thailand's reversal, however, provides a warning: trends can be reversed, political winds can change, and conservative counterattacks can also succeed.

The future of cannabis policy depends on whether legalizing countries can prove that regulation is more effective than prohibition. If legalization leads to a surge in usage rates, increased youth addiction, or worsening public health, opponents will have ample arguments.

The cautious models of Uruguay and Germany may be more sustainable than California's commercialized model. The core of legalization lies in harm reduction, not in maximizing profits or taxes.

The experience of the cannabis shift suggests that policy reform requires patience, caution, and supporting measures; hasty legalization may bring about greater problems than maintaining a ban.

The spectrum of cannabis policy also reveals a clue that is easily overlooked. In markets where prohibition is most severe, the THC content of cannabis has tripled over the past twenty years. To increase value within a smaller volume, growers continuously select and breed high-potency strains. This logic is identical to that of fentanyl replacing heroin: prohibition drives up the risk premium, high-potency strains have lower unit smuggling costs, and user tolerance drives them to seek stronger effects.

The true significance of the cannabis shift lies not in whether a particular country chooses legalization or prohibition, but in the low-intensity observation window it provides: even for the mildest of drugs, the evolutionary pressure of prohibition is creating more dangerous products.

Deaths of Despair

In January 2025, the Sackler family agreed to pay $7.4 billion to settle all civil lawsuits regarding the opioid crisis.

While this figure seems massive, compared to the over $10 billion in profits the family extracted from Purdue Pharma, it is merely a cost of doing business.

More concerning is that not a single family member has been sentenced to prison for triggering the worst public health disaster in modern American history.

The Original Sin of OxyContin

In 1996, Purdue Pharma launched OxyContin, a sustained-release formulation of oxycodone.

The company adopted an extremely aggressive marketing strategy, sending sales representatives across the country to pitch this "revolutionary" painkiller to doctors. They claimed that OxyContin had an addiction rate of less than 1% because the sustained-release formula prevented abuse.

This script was identical to that of the tobacco industry. In the 1950s, when faced with evidence of lung cancer, tobacco companies chose to deny, obfuscate, and continue marketing; Purdue Pharma did the same when faced with evidence of addiction. The difference is that it took 50 years to hold tobacco companies accountable, while it took Purdue only 25 years—indicating progress, albeit slow.

However, this claim was an outright lie. Internal documents from Purdue Pharma show that company executives were long aware of OxyContin's addiction risks. They chose to conceal this information and continue driving sales, instructing sales representatives to downplay addiction risks and exaggerate the drug's safety.

Doctors believed these claims, and prescriptions skyrocketed. Between 1996 and 2001, OxyContin sales grew from $48 million to over $1 billion. Millions of Americans began taking the drug, and many became addicted as a result.

From Prescription to the Streets

OxyContin triggered the first wave of opioid addiction.

Initially, addicts could obtain the drug through legal channels. They obtained prescriptions from multiple doctors or forged them, making "doctor shopping" a common phenomenon.

In the 2010s, regulations tightened. Prescription monitoring programs made "doctor shopping" difficult, and Purdue Pharma was forced to reformulate OxyContin to make it harder to crush and inject.

For those already addicted, the tightening of regulations brought disaster: when legal channels were cut off, addicts turned to the streets. Heroin was much cheaper than prescription drugs and offered a similar effect, leading to a surge in heroin demand, falling prices, and rising purity.

Subsequently, fentanyl flowed into the market. OxyContin's aggressive marketing created the demand, tightened regulations pushed that demand into the black market, and the black market met it with cheaper, more dangerous products.

This is a straight line from pharmaceutical company boardrooms to the morgue.

Deaths of Despair

In 2015, Princeton University economists Angus Deaton and Anne Case discovered a shocking trend: mortality rates among middle-aged white Americans were rising.

This was completely contrary to global trends, as mortality rates for all age groups were falling in almost all developed countries, with middle-aged white Americans being the sole exception.

Deaton and Case named this phenomenon "Deaths of Despair." The causes of death primarily included three categories: drug overdose, alcoholic liver disease, and suicide.

Deaths were concentrated in specific geographic regions: the Rust Belt, Appalachia, and rural areas. These places shared commonalities: the disappearance of manufacturing jobs, the collapse of community structures, and bleak economic prospects.

The opioid overdose death rate in Ohio was three times that of California, and at one point, the number of prescription opioids per capita in West Virginia reached over 50 doses per person per year.

The distribution was not accidental; it was a reflection of economic geography.

After the Factories Closed

In the 1970s, Youngstown was a steel powerhouse in Ohio. Steel mills provided high-paying blue-collar jobs that supported the prosperity of the entire community.

In 1977, the steel mills began to close, and by the end of the 1980s, Youngstown had lost over 50,000 manufacturing jobs.

The factory closures took away more than just jobs; they led to the dissolution of unions, the closure of community centers, dwindling church congregations, and the exodus of young people, eventually leaving behind only unemployment, poverty, and despair.

When NAFTA sent more manufacturing jobs to Mexico, when automation replaced assembly line workers, and when the economic foundation of an entire community collapsed within a single generation, chemical solace became the only outlet.

Opioids bring escape, not solutions; they numb the pain rather than fix the problem. For someone who has lost their job, dignity, and future, this numbness is extremely seductive.

The opioid crisis in the Rust Belt is not a moral failing but a product of economic policy.

The Pendulum Effect

The pendulum effect of policy brought secondary disasters: in 2016, the CDC issued guidelines for opioid prescriptions aimed at curbing over-prescription, advising doctors to be cautious in prescribing opioids and to prioritize non-opioid pain management options.

While the intention was good, the result was a catastrophe. Millions of legitimate pain patients were cut off from their medication. Chronic pain patients, cancer patients, and post-operative patients suddenly found themselves unable to obtain the painkillers they needed.

Some doctors went to the other extreme, refusing to prescribe opioids altogether. Pain patients were forced to scramble between multiple clinics or turn to the streets to buy counterfeit pills of unknown composition.

In 2022, the CDC had to revise the guidelines, acknowledging that excessive restrictions had caused harm. The new guidelines emphasized individualized treatment rather than a one-size-fits-all control approach.

The logic of "good intentions leading to bad outcomes" is vividly illustrated here. In a complex addiction ecosystem, single-dimensional interventions often lead to unintended negative consequences.

The Rise of Tranq

The streets of the Kensington district in Philadelphia are now filled with a substance called "Tranq."

Tranq is the street name for Xylazine, a veterinary sedative originally used to anesthetize horses and cattle. It is mixed into fentanyl to prolong the high.

Xylazine is not an opioid, so Naloxone cannot reverse its effects. When an overdose victim remains unresponsive after being injected with Naloxone, first responders know Xylazine is involved.

Worse still, the side effects of Xylazine cause severe skin ulcerations. Wounds start at the injection site and spread outward like burns, causing tissue necrosis and exposing muscle and bone. The spread of infection has led to a massive increase in amputation rates.

In Kensington, young people with missing arms or legs and oozing wounds are a common sight. This is no longer just about overdose deaths; it is large-scale disablement.

The popularity of Tranq reveals a cruel reality: when one drug is suppressed, a more dangerous substitute appears. Fentanyl replaced heroin, and Xylazine is now "enhancing" fentanyl.

The $7.4 Billion Settlement

The $7.4 billion will be used for opioid crisis treatment and prevention programs. This funding will be distributed to state and local governments to build drug rehabilitation centers, train medical personnel, and distribute Naloxone.

Critics point out that this money is far from enough. The economic losses caused by the opioid crisis are estimated to exceed $1 trillion, with costs for healthcare, lost productivity, law enforcement, and family breakdown being difficult to measure in monetary terms.

More critically, there is a lack of accountability. Members of the Sackler family began transferring assets out of Purdue Pharma before the crisis fully erupted. By the time the company filed for bankruptcy, the family's wealth was safely tucked away in trusts and offshore accounts. The $7.4 billion settlement comes from these transferred assets, not from the personal liability of family members.

No one went to prison, and no one was held criminally responsible; the decision-makers who caused hundreds of thousands of deaths ultimately just signed a check.

This is a footnote to the American justice system: corporations can kill, as long as they can afford the fine.

The Treatment Gap

Methadone maintenance treatment is currently the most evidence-based method for treating opioid addiction. By providing a long-acting, oral opioid, methadone eliminates withdrawal symptoms and cravings, allowing addicts to return to a normal life.

Data shows that for addicts receiving methadone treatment, crime rates drop by more than 60%, employment rates gradually recover, and HIV infection rates decrease accordingly.

However, the accessibility of treatment has become a problem. In the United States, methadone can only be obtained at specialized clinics, requiring patients to travel there daily and take the medication under staff supervision. For addicts living in rural areas without transportation, this is nearly impossible.

Buprenorphine is another option that can be prescribed by regular doctors. Before 2023, American doctors needed a special license to prescribe buprenorphine. Even after these restrictions were lifted, doctors willing to prescribe it remain scarce.

The supply of treatment lags far behind demand, with waiting lists stretching for months. Many addicts die while waiting for treatment.

Structural Issues

The root of "deaths of despair" lies not in drugs, but in despair itself.

A person living in a stable community with a job and family support has a much lower probability of addiction, even if they have tried drugs, compared to someone who is unemployed, lonely, and living in a decaying community.

The experience of Vietnam War veterans supports this. In Vietnam, about 20% of US soldiers used heroin, and many were heavily addicted. The military expected these individuals to become a massive social problem upon their return.

In reality, most veterans naturally stopped using after returning home without receiving any treatment. The addiction phenomenon faded once the environment changed; once the fear and loneliness of the battlefield vanished, heroin lost its appeal.

This case illustrates that addiction is not just about chemical substances; it is about the environment of survival.

As long as social structures continue to produce despair, no amount of law enforcement can stop people from seeking anesthesia. The Sackler family lit the fire, and economic policy provided the fuel.

Extinguishing the fire requires not more firefighters, but a stop to adding more fuel.

Darknet Empire

In January 2025, Donald Trump signed a pardon for Ross Ulbricht.

Ulbricht, the founder of "Silk Road," spent 12 years in prison. This pardon was viewed as a victory by crypto-anarchists and as a setback by law enforcement agencies.

For the darknet ecosystem, this is merely a symbolic footnote. Silk Road has long since become history. Today's darknet market scale is dozens of times larger than Silk Road was at its peak.

The Legacy of Silk Road

In 2011, Ross Ulbricht created Silk Road, an online marketplace accessible only through the Tor network.

The philosophy of Silk Road was libertarian: adults should have the right to decide what substances they ingest, and the government has no right to interfere. Ulbricht believed that by eliminating the risk of violence associated with street transactions, darknet markets could actually reduce the harm of the drug trade.

To some extent, Ulbricht was right: there were no street shootouts on Silk Road. Buyers did not need to walk into dangerous neighborhoods, and sellers did not need to hire armed bodyguards; both parties to the transaction hid under the protection of encryption technology.

Silk Road also introduced a revolutionary mechanism: the user rating system. Buyers could rate sellers on product quality, shipping speed, and customer service. Negative reviews could ruin a seller's business, creating a market discipline that forced sellers to provide high-quality products.

Ironically, the spirit of fulfillment in darknet markets is even stricter than that of many legal e-commerce platforms.

The Miracle of Trust

Darknet markets face a profound problem: how to build trust in an environment where both buyers and sellers are criminals and there is no legal protection?

The answer is the Escrow system: the buyer pays Bitcoin into an escrow account controlled by the market, the seller ships the goods, and after the buyer confirms receipt, the market releases the funds to the seller. If the buyer does not receive the goods, they can apply for a refund.

The system is not perfect. Market administrators can abscond with funds (an "exit scam"), sellers can send counterfeit goods, and buyers can falsely claim they did not receive the items.

Nevertheless, the system works surprisingly well. Most transactions are completed smoothly, disputes are resolved through the market's arbitration mechanism, and reputation has become the most valuable asset.

In a completely anonymous and entirely illegal environment, humans have managed to establish an effective trust mechanism. This is the most surprising achievement of darknet markets.

This path is not without precedent. eBay in the 1990s faced the same dilemma: how do strangers complete remote transactions? eBay's answer was also escrow plus ratings: PayPal locked the funds, and star ratings filtered out scammers. Silk Road almost carbon-copied this mechanism, merely swapping second-hand cameras for cocaine. The evolutionary trajectories of the two markets are strikingly similar: both started in the "Wild West," both achieved self-purification through reputation systems, and both faced platform governance crises after expanding in scale. The only difference is that eBay eventually gained legal protection, while Silk Road gained an FBI search warrant.

The Hydra Effect

In 2013, the FBI shut down Silk Road and arrested Ulbricht.

Law enforcement agencies declared victory. The reality was that the closure of Silk Road was only the beginning of the evolution of darknet markets.

Within 48 hours, multiple alternative markets went online. Silk Road 2.0, Agora, Evolution, AlphaBay—each was larger, more secure, and harder to penetrate than its predecessor.

This is the Hydra effect: cut off one head, and two more grow back.

Every law enforcement action is an act of natural selection. Closed markets expose security vulnerabilities, and surviving markets learn the lessons. New market administrators study the failures of their predecessors to design stronger defenses.

In 2017, when AlphaBay was shut down, its scale was already ten times that of Silk Road. In 2023, when the Russian-language Hydra was shut down, its annual transaction volume exceeded $5 billion.

Every "victory" makes the next one harder.

The Rise of the Russian-speaking Sector

The geographical center of gravity for darknet markets is shifting eastward. Early darknet markets primarily served English-speaking users, with servers located in Western countries and payments made in Bitcoin. These markets were relatively easy for Western law enforcement to penetrate.

Russian-language markets are different. Hydra was the largest Russian darknet market and operated for nearly a decade before being shut down. One of Hydra's secrets to success was the "Dead Drop" system: sellers hide drugs in public places (parks, abandoned buildings, tree hollows), and buyers pick them up themselves after receiving GPS coordinates. There is no mailing, no courier tracking, and no logistical evidence.

Russian markets also benefit from geopolitics. Russian law enforcement has limited interest in cracking down on darknet markets that serve their own citizens. As long as the market does not export to the West, it can operate relatively safely.

After Hydra was shut down, multiple successors quickly filled the void. The resilience of the Russian-language darknet ecosystem frustrates Western law enforcement.

The Evolution of Cryptocurrency

Bitcoin was once thought to be anonymous, but this is actually a misunderstanding.

All Bitcoin transactions are recorded on a public blockchain. While addresses are anonymous, transaction patterns can be analyzed. Blockchain analysis companies (such as Chainalysis) have developed sophisticated tools to track fund flows and identify suspicious addresses.

The response from darknet markets has been the evolution of cryptocurrency: Bitcoin Mixers blend the Bitcoins of multiple users together to disrupt the transaction chain. Users deposit Bitcoin and withdraw an equivalent amount of "clean" Bitcoin, making tracking difficult.

Monero is a more complete solution. This cryptocurrency is designed to be untraceable; transaction amounts, senders, and receivers are all encrypted and hidden. Even blockchain analysis companies cannot track the flow of Monero.

An increasing number of darknet markets are starting to accept only Monero, and Bitcoin is gradually being phased out.

Cross-chain bridging technology is the latest development. Users can convert one cryptocurrency into another across multiple blockchains, further obscuring the source of funds. Tracking fund flows has become like finding patterns at the level of quantum physics.

Vulnerabilities in the Postal System

The logistics of darknet markets rely on an unexpected ally: the ordinary postal system.

The US Postal Service processes hundreds of millions of pieces of mail every day. It is impossible for customs and postal inspectors to check them one by one. Even with X-ray machines and drug-sniffing dogs, the rate of items slipping through remains extremely high.

Darknet sellers have developed sophisticated concealment techniques, using vacuum sealing to eliminate odors and multi-layer packaging to prevent X-ray detection, mixing packages disguised as legal goods (books, electronics, clothing) into the normal mail stream.

International mail is even harder to inspect. A package sent from the Netherlands to the United States must pass through the customs of both countries, and every link has vulnerabilities that can be exploited.

The emergence of fentanyl has made the problem even more severe. The amount of fentanyl in a standard envelope is enough to supply the weekend needs of a medium-sized city. Detecting such minute quantities of the substance is nearly impossible.

The postal system was designed for legal commerce and cannot cope with the micro-scale smuggling of drugs.

The Paradox of Quality Control

Darknet markets have created a peculiar phenomenon: quality control for illegal drugs.

In street transactions, buyers have no way of knowing the purity and composition of the drugs; adulteration is the norm, and lethal fentanyl can be mixed into any substance.

Darknet markets have changed the situation. A seller's reputation depends on product quality, and negative reviews can ruin a business. Some sellers even provide laboratory test reports to prove the purity and composition of their products, and buyers can read hundreds of reviews before purchasing.

This brings about a paradox: illegal markets provide safer products than the streets.

Some harm reduction advocates argue that darknet markets actually reduce drug harm. Buyers know what they are ingesting and can control dosages more accurately, thereby reducing the risk of adulteration and accidental overdose.

This argument sparks controversy at the ethical level, but it has some support in the data.

The Dilemma of Law Enforcement

Law enforcement agencies face a dilemma when dealing with darknet markets.

Traditional undercover operations have limited effectiveness on the darknet. Building credibility takes time, and a market can close at any moment. Penetrating a market takes months or even years, and the harvest may only be a few mid-level sellers.

Technical means are also limited. The design of the Tor network makes tracking users almost impossible, and the anonymity of cryptocurrencies makes tracking fund flows nearly unsolvable.

The most effective strategy is to attack infrastructure, such as shutting down markets, arresting administrators, and seizing servers. This does cause short-term chaos, but in the long run, new markets always emerge.

Some law enforcement agencies have tried more aggressive strategies: taking over a market instead of shutting it down outright, collecting user data, and then conducting mass arrests. This strategy is effective in the short term, but in the long run, it only accelerates the evolution of the market.

The darknet market is an antifragile system; the greater the pressure, the faster it adapts.

Alternatives through Legalization

The existence of darknet markets raises a sharp question: if illegal markets cannot be eliminated, should legal alternatives be created?

Some countries are already experimenting. Switzerland provides prescription heroin to severe heroin addicts, and Portugal has decriminalized the possession of all drugs, shifting resources from law enforcement to treatment.

The logic of these policies is: if people are going to use drugs anyway, it is better to let users use safer products in a controlled environment.

Darknet markets prove this logic in a twisted way. Those markets provide the quality control and consumer protection that street transactions lack. If legal markets could provide the same functions, darknet markets would lose their reason for existence.

Of course, this requires society to accept a challenging premise: the use of certain drugs is difficult to eliminate, and the goal of policy should be management rather than eradication.

The Future of the Darknet

Darknet markets will not disappear.

Technology is advancing. Decentralized markets are under development, where there are no central servers to shut down and no administrators to arrest. Smart contracts can automatically execute escrow functions.

Cryptocurrencies are evolving. Privacy coins are becoming increasingly difficult to track, and cross-chain technology makes fund flows even more hidden.

Law enforcement is catching up, but always remains one step behind.

Ross Ulbricht's pardon is a symbol. The market Ulbricht created has long since perished, but the seeds sown by Silk Road have grown into a forest. The philosophy of Silk Road—that adults have the right to decide what they ingest—echoes in every corner of the darknet.

Whether this philosophy is correct is a value judgment. The existence of darknet markets itself is a silent testament to the failure of prohibition.

The evolutionary history of the darknet is a digital microcosm of the War on Drugs thesis. Economics provides the inexhaustible drive; the excess profits created by prohibition are sufficient to support every generation of platforms' investment in security technology. Neuroscience locks in a demand that is difficult to eliminate: addicts will not stop buying just because a market is shut down. Every law enforcement "victory" acts as a selection mechanism: weeding out platforms with poor security, leaving behind more hidden survivors, while simultaneously pushing transactions toward harder-to-track cryptocurrencies and more micro-scale logistics. From Silk Road to Hydra, Bitcoin to Monero, centralization to decentralization—every iteration of the darknet is another length ahead as the law tries to catch up with economic incentives.

From Death Penalty to Prescription

On June 30, 2016, Rodrigo Duterte was sworn in as President of the Philippines, and on the same day, he announced a "shoot-to-kill" policy against drug traffickers. Six years later, more than 6,000 people had died in extrajudicial killings, and the price of methamphetamine had returned to its original level.

In the same year, Portugal celebrated the 15th anniversary of drug decriminalization. Its overdose death rate remained the lowest in Europe, HIV infection rates had dropped by 95%, and not a single person was in prison for drug possession.

These two countries represent two philosophies and two outcomes; the divergence in global drug policy has never been clearer.

The Singapore Model: Zero Tolerance

Singapore's drug laws are among the harshest in the world. Trafficking more than 15 grams of heroin, 30 grams of morphine, or 500 grams of cannabis carries a mandatory death sentence, with neither judicial discretion nor the possibility of commutation. Since 1991, Singapore has executed more than 400 drug offenders.

Punishments for users are equally severe. First-time drug use can result in long-term imprisonment and mandatory rehabilitation, while repeat offenders face longer sentences and caning.

Singapore's drug use rate is indeed very low. Official data shows that the proportion of drug users in the population is less than 0.1%, far lower than in most developed countries.

Supporters argue this proves the effectiveness of strict laws and harsh punishments—the deterrence mechanism works, and potential users and traffickers are deterred by the fear of the death penalty.

Critics point out that Singapore, as a city-state with an area of only 720 square kilometers, has highly controllable borders—a geographical condition that does not exist in most countries. At the same time, Singapore's political culture, which emphasizes obedience to authority and collective interest, makes citizens highly accepting of government intervention in private life. This cultural background is not replicable in Western democracies.

A deeper question is whether it is justifiable to use the state's machinery of violence to deprive a citizen of life for the sake of a substance. Singapore's success is built on the premise that the government has the right to decide what substances citizens ingest and that violators can be put to death—a premise to which different societies will have different answers.

The Philippines Model: Extrajudicial Violence

In 2016, Rodrigo Duterte was elected President of the Philippines on a promise to eliminate the drug problem within six months. His method was extrajudicial killings, publicly encouraging the police and vigilantes to kill drug traffickers and users. His original words were blunt: "If you know of any addicts, go ahead and kill them yourself."

Official data states that the drug war resulted in approximately 6,000 deaths, while human rights organizations estimate the true figure to be between 12,000 and 30,000. Many victims had no criminal record and were merely reported by neighbors or suspected by the police.

However, the price of methamphetamine stabilized quickly after only short-term fluctuations. Supply was never truly interrupted, and by the end of Duterte's term, the drug problem in the Philippines was virtually indistinguishable from when he took office.

In 2024, the International Criminal Court launched an investigation into Duterte's war on drugs, determining that there was evidence of crimes against humanity.

The lesson of the Philippines model is that violence itself cannot solve the problem. Even if one is willing to pay the price of tens of thousands of lives, the supply chain remains intact and demand persists; violence eventually becomes an end in itself.

The Oregon Model: Decriminalization Without Support

In 2020, Oregon passed Measure 110, becoming the first state in the United States to decriminalize the possession of all drugs. Possession of small amounts of heroin, cocaine, and methamphetamine was downgraded to a minor violation, punishable by a $100 fine or waived by attending a health assessment. The savings from enforcement and incarceration were intended to be used to build drug treatment facilities.

Its progressive philosophy lay in decoupling the drug problem from the criminal justice system and bringing it into the realm of public health, aiming to remove criminal penalties and help those with addictions.

However, the execution was disastrous. The promised treatment services never truly materialized. Funding allocation was slow, and bureaucratic procedures were cumbersome. The construction of treatment facilities lagged far behind schedule, resulting in decriminalization taking effect while supporting measures failed to keep up.

The streets of Portland became venues for open drug use. Tent encampments spread, and overdose death rates rose instead of falling. The collapse of public order led to widespread complaints from residents and businesses.

In 2024, the Oregon State Legislature voted to repeal the core provisions of Measure 110 and re-criminalize drug possession as a misdemeanor. In just four years, it went from being a "pioneer" to a "failure."

The lesson of Oregon is that decriminalization does not mean abdication. Decriminalization without the support of public health infrastructure is merely the government opting out of its responsibilities.

The Portugal Model: Medicalization and Harm Reduction

In 2001, Portugal decriminalized the personal possession of all drugs. This was a response to the heroin crisis of the 1990s, when Portugal's HIV infection and overdose death rates were the highest in Europe.

The Portuguese model is fundamentally different from Oregon's. Its decriminalization is accompanied by mandatory public health intervention. People found in possession of drugs are exempt from arrest but are instead summoned by a "Dissuasion Commission" composed of lawyers, social workers, and psychologists for assessment, where they receive treatment recommendations or are mandated to participate in rehabilitation programs.

This approach is by no means laissez-faire; it is essentially the replacement of the criminal justice system with a medical system.

Data from more than twenty years later shows that Portugal's new HIV infection rate has dropped by more than 95%, the overdose death rate has fallen from the highest in Europe to one of the lowest, and drug use rates have remained stable without the predicted surge. Meanwhile, the prison population has seen a long-term decline, releasing significant public resources.

The success of the Portuguese model is built on a solid political consensus. Decriminalization was supported by both the left and the right, viewed as a public health measure rather than an ideological stance. At the same time, the government provided sufficient supporting investment by increasing funding for drug treatment, needle exchanges, and methadone maintenance treatment year after year. Furthermore, as a relatively homogeneous small country, Portugal's strong social cohesion provided a favorable cultural background for the smooth implementation of the policy.

The Switzerland Model: Prescription Heroin

Switzerland has gone further than Portugal. Since 1994, it has provided prescription heroin to severe heroin addicts. Addicts can go to clinics twice a day to inject medical-grade heroin under medical supervision.

The target group for this project is "hardcore" addicts for whom methadone and other treatment methods have been ineffective and who have experienced multiple failed attempts at rehabilitation.

The results show that the crime rate among participants has dropped by more than 60%. Addicts no longer need to resort to theft and robbery to fund their drug use. Meanwhile, employment rates have steadily recovered, and both health status and social functioning have been restored.

The Swiss government estimates that each patient participating in heroin-assisted treatment saves society approximately $45,000 per year. The reduced costs of crime, law enforcement, emergency services, and incarceration far exceed the cost of treatment.

The logic of the Swiss model is pragmatic: if a person is going to use heroin regardless, it is better to let the addict use a clean product in a controlled environment rather than using drugs of unknown origin on the street.

This logic makes many people morally uncomfortable, raising questions about whether the government providing heroin is equivalent to condoning or even encouraging drug use. Switzerland's answer is that the target group are already addicts and that prohibition has failed to stop the addictive behavior. Therefore, the core question has moved beyond "should anyone use drugs" to "since people are using drugs, how can we reduce the harm?"

Comparison of Models

The four models represent different positions on the policy spectrum.

The Singapore model is effective only under specific conditions that most countries do not possess. The Philippines model is a failure that has achieved nothing except causing death. In contrast, the Oregon model proves that good ideas require good execution, while the Portugal and Switzerland models provide the most evidence-based alternatives currently available.

Why Portugal Succeeded and Oregon Failed

Both implemented decriminalization, yet the results were vastly different. Portugal implemented "managed decriminalization." People found in possession of drugs must face a Dissuasion Commission for assessment and may be mandated for treatment. The state did not step away; it only changed the method of intervention.

Oregon, on the other hand, implemented "abandonment-style decriminalization." While removing criminal penalties, it failed to establish alternative mechanisms. The $100 fine was a mere formality, health assessments were voluntary, and treatment facilities were scarce. The state was effectively in a state of withdrawal.

Portugal had established a comprehensive treatment network before decriminalization, whereas Oregon only began slow construction after decriminalization. This is similar to the logic in healthcare reform of "building infrastructure before expanding coverage." Oregon made the mistake of announcing decriminalization before building the treatment network, leading to unfulfilled promises and a collapse of public trust.

Furthermore, Portugal possessed a broad political consensus, while Measure 110 in Oregon, implemented through a referendum, faced resistance from many law enforcement agencies and local governments from the very beginning.

Therefore, Oregon's setback stems from the implementation level and is unrelated to the philosophy of decriminalization itself. It attempted to mimic Portugal's "not arresting people" but ignored the supporting "managing people" mechanism.

No Panacea

The comparison of the four models points to an uncomfortable fact: there is no panacea.

Singapore's success is not replicable, Portugal's success depends on specific political and social conditions, and Switzerland's prescription heroin faces political infeasibility in many countries. Every society must make choices based on its own conditions, but what is certain is that purely punitive methods bring huge human rights costs, while purely laissez-faire methods lead to the collapse of public order.

The medicalization model in between currently appears to be the choice with the lowest social cost. This model acknowledges the reality that some people will always use drugs regardless of how strict the laws are. Therefore, policy goals must abandon the utopian "drug-free world" and turn toward pragmatically reducing harm. This conclusion may make both supporters of the war on drugs and advocates of complete liberalization feel uncomfortable, as it still advocates for state intervention, just in a different way.

Conclusions that make both sides uncomfortable are often closest to the truth.

The success or failure of the four models is, ultimately, different reports from the same war. Economics determines the resilience of supply; a market with profit margins as high as several thousand times will not disappear just because penalties are increased to the death penalty. Neuroscience determines the rigidity of demand; a reshaped brain will not stop craving because of changes in legal statutes. Singapore used extreme control to suppress usage rates but cannot export its model; the Philippines used extreme violence in an attempt to eliminate supply, yet the price of methamphetamine remained unmoved. The two extremes together prove that when economic incentives and neurological mechanisms join forces, the law can only choose how to distribute the harm, but is powerless to eliminate the harm itself. The pragmatism of Portugal and Switzerland lies in their being the first to acknowledge the unwinnability of this war, turning instead to managing the consequences.

The Harm Reduction Revolution

Between 2024 and 2025, the number of drug overdose deaths in the United States saw a historic decline.

The border walls were not raised higher, nor were more drug lords imprisoned. The real shift occurred in emergency rooms, community centers, and street corners: the distribution of Naloxone reached a critical tipping point.

When policy goals shifted from "eliminating drugs" to "reducing deaths," the death toll began to fall.

Dead People Cannot Recover

The harm reduction movement has a slogan: "Dead people cannot recover."

This phrase reveals a simple truth: if the hope is for addicts to eventually quit drugs and return to a normal life, the prerequisite is ensuring they stay alive.

A person who dies of an overdose loses the chance for recovery forever. A person who contracts HIV from sharing needles will fight the disease for the rest of their life. A person arrested for injecting on the street will find their future path to employment and housing blocked by a criminal record.

The core philosophy of harm reduction is based on this logic: no matter how strict the laws are, some people will always use drugs. Humans have a history of using psychoactive substances spanning over ten thousand years, and no society has ever successfully eliminated such behavior. Since this is the case, the goal of policy should not be a utopian "drug-free world"—a goal that 55 years of the War on Drugs has proven unachievable—but rather the pragmatic reduction of harm.

This follows the same public health logic as seatbelts and condoms. In the 1960s, opponents of seatbelts argued they would "encourage reckless driving"; in the 1980s, those opposing the promotion of condoms believed they would "encourage promiscuity." History has proven these concerns wrong. Acknowledging the existence of risky behavior and reducing its harm is more effective than pretending the risk does not exist.

The prohibitionist mindset views drug users as criminals or morally corrupt individuals who need to be punished or reformed; the harm reduction mindset views drug users as people in need of help, even if they have made "wrong" choices. The divergence between these two mindsets is not just technical, but philosophical.

Evidence: Four Tools, One Logic

The concept of harm reduction is implemented through four core tools, each following the same logic: buying time for the addict.

Naloxone is an opioid antagonist that can reverse an opioid overdose within minutes, pulling a dying person back from the brink of death. This drug was developed as early as the 1960s and has been a standard fixture in emergency rooms for decades. What changed was not the drug itself, but the method of distribution. Activists pushed for legislation to allow ordinary people to access and use Naloxone; pharmacies began selling it without a prescription, and community organizations distributed it for free on the streets. Families of drug users and even passersby can now carry this life-saving medication. In 2023 alone, over 5 million doses of Naloxone were distributed in the United States.

While Naloxone saves those who have already overdosed, Fentanyl Test Strips provide an early warning before an overdose occurs. Users only need to dissolve a small amount of the drug in water and dip the strip to know the results in minutes. Fentanyl can be laced into any substance, including heroin, cocaine, methamphetamine, or even counterfeit prescription pills; users often do not know what they are consuming. A test strip costing less than $1 can be the line between life and death. By 2024, most states had legalized fentanyl test strips, whereas previously, these strips were classified as "drug paraphernalia" in many states, making possession illegal.

Syringe Exchange Programs are one of the earliest achievements of the harm reduction movement. Sharing needles is a primary route for the transmission of HIV and Hepatitis C. During the AIDS crisis of the 1980s, injection drug users were among the groups with the highest infection rates. Syringe exchange programs provide free clean needles and collect used ones; users do not need to provide identification, will not be arrested, and are not lectured. Research shows these programs can reduce HIV infection rates by over 50% while providing a channel to reach difficult-to-access populations. Many programs also provide health screenings, addiction treatment referrals, and social service information. Opponents once feared that syringe exchanges would "encourage" drug use, but data shows this concern is baseless: drug use rates in areas covered by these programs did not rise; instead, more people entered addiction treatment due to contact with the service system.

Supervised Consumption Sites are the most controversial projects in the harm reduction movement. In these facilities, drug users can use their own drugs under the supervision of medical personnel. The facilities provide clean needles, a sterile environment, and immediate assistance in the event of an overdose. Insite in Vancouver, Canada, was the first legal supervised consumption site in North America and has operated for over 20 years. Inside Insite, the overdose death rate is zero, crime rates in the surrounding community have not risen, and HIV and Hepatitis C infection rates continue to decline. A 2026 study showed that public injection behavior, discarded needles, and emergency calls decreased around supervised consumption sites. The United States currently has only two legal supervised consumption sites, both located in New York City, which still face legal challenges and political opposition.

These four tools share the same logic: Naloxone lets the addict survive today, clean needles prevent infection, test strips let them know what they are consuming, and supervised consumption sites keep them connected to the service system. Perhaps tomorrow, perhaps next year, or perhaps ten years from now, these individuals will be ready to accept treatment, and harm reduction ensures they live to see that day.

The Economic Account

Harm reduction is not only a humanitarian consideration but also an economically wise choice.

To send an addict to prison, taxpayers must pay approximately $40,000 per year. After release, these individuals face employment discrimination, housing difficulties, and social exclusion, leading to high recidivism rates. Incarceration does not solve the problem; it merely postpones it while consuming vast public resources.

Providing Methadone or Buprenorphine treatment costs only a fraction of the cost of incarceration. Addicts receiving treatment can work, pay taxes, and care for their families, transforming from a social burden into social contributors.

Switzerland's prescription heroin program also proves this point: the social benefits of treatment far outweigh the costs, as the reduction in spending on crime, law enforcement, emergency services, and incarceration fully covers the cost of treatment.

The math is simple: punitive methods are high-cost and low-effect, while harm reduction methods are low-cost and high-effect.

So, why do many societies still choose the former? Because policy choices are not just economic calculations; they involve moral concepts, political interests, and cultural biases.

Political Resistance

Conservative critics argue that harm reduction is "condoning" drug use and sending the "wrong message." They fear that if drug use is made "safer," more people will try drugs.

This concern seems reasonable, but the data does not support it.

Portugal has implemented harm reduction policies for over twenty years, and drug use rates have not risen. Switzerland has provided prescription heroin for thirty years and has not seen a new wave of addiction. Syringe exchange programs exist worldwide, and there is no evidence that these programs increase the number of drug users.

Harm reduction measures target people who are already using drugs, not potential new users. A person who has never touched drugs will not decide to start just because they know a supervised consumption site exists.

The true root of political resistance may not be skepticism about effectiveness, but a fear of appearing "weak." In many political cultures, being "tough" on drugs is a virtue, and any policy that appears "weak" will be attacked.

Harm reduction requires political courage: admitting the war has failed, admitting punishment is ineffective, and admitting the need for a different way.

The 2024 Turning Point

Returning to the data at the beginning: in 2024-2025, the number of drug overdose deaths in the United States declined, marking the first time harm reduction strategies showed nationwide effectiveness.

The reasons for the decline are multifaceted, with the widespread distribution of Naloxone being the most significant factor. The legalization and popularization of fentanyl test strips also played a role, while some states expanded access to Methadone and Buprenorphine.

It is too early to call it a victory, but a turning point has emerged. Although tens of thousands still die from overdoses every year, fentanyl still floods the streets, and new threats like Xylazine are surfacing.

Harm reduction has proven it can save lives. The question is: is society willing to fully embrace this approach?

While the DEA displays tons of seized fentanyl at the border, what truly saves lives are the millions of doses of Naloxone distributed in communities. This contrast says it all: law enforcement is political performance; harm reduction is actual action.

The choice depends on what society truly wants—to look "tough," or to let more people survive.

Harm reduction works because it is the first strategy that does not attempt to defeat economics and neuroscience. Fifty-five years of the War on Drugs have repeatedly proven: economic incentives drive supply to constantly evolve (from heroin to fentanyl to Nitazenes), and neurological mechanisms lock in demand that is difficult to eliminate (the brains of addicts do not change because of upgraded laws). Every round of law enforcement escalation clears market space for the next generation of more lethal drugs, while harm reduction bypasses this death spiral. It does not try to cut off supply, nor does it try to eliminate demand; it simply ensures that as economics and neuroscience continue to join forces to defeat the law, as few lives as possible are lost. This is not a surrender, but a tactical adjustment after acknowledging the reality of the battlefield.

Alternative Economies

In the Putumayo province of Colombia, one hectare of coca can generate approximately $6,000 in annual income, while the same area of coffee or cassava yields less than $600. This tenfold disparity explains why decades of eradication efforts have consistently failed. For impoverished farmers in the Andes, growing coca is not an act of criminality, but a means of survival.

Without a viable alternative economy, forced eradication only leads to famine.

The Failure of Plan Colombia

In 1999, the United States launched "Plan Colombia," the largest anti-drug assistance project in history. Over 15 years, the U.S. poured more than $10 billion into Colombia, primarily for military aid such as helicopters, weapons, training, and intelligence. Aerial herbicide spraying became the core tactic, with millions of hectares of coca fields covered in glyphosate.

By 2024, Colombia's cocaine production reached record highs, with cultivation areas larger, purity higher, and prices lower than when the plan began. The $10 billion investment resulted in even more severe problems: while aerial spraying did destroy coca fields, farmers simply moved to more remote areas, clearing more rainforest to open new plots. The "balloon effect" manifested once again—compressing it in one place caused it to expand in another. Worse still, glyphosate destroyed not only coca but also surrounding legal crops. After losing income from both coca and food crops, farmers were left with no choice but to continue growing coca.

The Iron Laws of Economics

To understand coca cultivation, one must understand rural economics. Farmers in the Andean region face multiple constraints.

Transportation costs are the greatest obstacle; moving goods from remote mountainous areas to markets often requires days of mule transport, and perishable agricultural products often spoil before reaching the market. Coca leaves, however, can be processed locally into coca paste, which is low-volume, high-value, and non-perishable. Market access is equally difficult; coffee and cocoa must enter international markets to fetch good prices, which requires quality certifications, supply chain integration, and branding resources that are difficult for farmers to obtain. Coca buyers actively come to the farm to purchase and settle in cash, with no intermediaries involved.

The ability of farmers to diversify risk is also extremely limited. Legal crops are affected by weather, pests, and market fluctuations, while coca demand is stable and prices are guaranteed. For farmers without savings or insurance, this stability is vital. Even if all the aforementioned obstacles are overcome, the income from legal crops remains only one-tenth that of coca, a gap so vast that any economic incentive struggles to bridge it.

The Dilemma of Alternative Development

The international community has attempted to help farmers transition to legal crops through "Alternative Development" projects, providing technology, market channels, and infrastructure. The results of such projects have been mixed. Thailand successfully transitioned its northern mountainous regions from opium cultivation to coffee, tea, and tourism in the 1980s, with the keys being long-term government commitment, large-scale infrastructure investment, and a relatively stable political environment. However, examples of failure are more numerous. In Afghanistan, Myanmar, and Colombia, alternative development projects have often been short-lived, with intermittent funding and projects repeatedly starting and stopping, leaving farmers frequently promised and frequently disappointed.

Alternative development faces a profound time mismatch: eradicating coca is fast—coca fields wither within weeks of herbicide spraying—but building an alternative economy can take years or even decades. Building roads, establishing cooperatives, cultivating markets, and changing planting habits are not short-term tasks. This is similar to the transition difficulties in U.S. coal country. After Appalachian coal mines closed, the "clean energy jobs" and "retraining programs" promised by politicians mostly failed to materialize thirty years later. Coal miners did not become programmers, and decaying small towns did not become tech hubs. The time required for industrial transformation is completely disconnected from political cycles, and the dilemma faced by coca farmers is even more extreme. Politicians need to show results within their terms, while true economic transformation requires long-term investment spanning multiple administrations.

Turkey's Success

Turkey is one of the few examples of a successful transition. In the 1970s, the country was a major global producer of illegal opium. Facing U.S. pressure to ban poppy cultivation, the Turkish government was caught in a dilemma: banning it would anger farmers, while not banning it would anger the U.S. Ultimately, the government established a legal medicinal poppy industry, signing contracts with farmers to purchase poppies at fixed prices to be processed into morphine and codeine for export to the global pharmaceutical market. This provided farmers with stable income, the government with tax revenue, and the U.S. with a satisfactory resolution.

The success of this model relied on strong state capacity. The Turkish government utilized an efficient bureaucracy and law enforcement to regulate cultivation, control processing, and crack down on illegal diversion. Meanwhile, the massive legal market for medicinal opioids was sufficient to absorb Turkey's production. Prices in legal channels were also attractive enough that farmers had no incentive to turn to the black market. However, these conditions are absent in Afghanistan and Myanmar.

Afghanistan's Impossible Mission

Afghanistan is a classic example of the failure of alternative development. The U.S. invested billions of dollars there in alternative development projects such as irrigation, providing seeds and fertilizer, and building roads and markets, but the results were nearly zero. Afghanistan's problems go far beyond the economic level; war destroyed infrastructure, corruption weakened government capacity, and the Taliban controlled vast rural areas. In such an environment, any development project is difficult to sustain. A deeper issue is that Afghanistan lacks a high-value crop that can replace the poppy. Saffron was once highly anticipated but has a limited market; pomegranates and almonds take years to bear fruit; and the prices of wheat and corn are too low.

In 2023, the Taliban used violent means to achieve what the U.S. could not, cutting poppy production by 95%, but the cost was millions of farmers losing their income and an intensifying humanitarian crisis. This illustrates a brutal reality: without an alternative economy, bans can only "succeed" by creating misery.

The Impasse in Myanmar

The situation in Myanmar's Golden Triangle is even more complex. Opium and methamphetamine production here are primarily controlled by ethnic armed groups that have been in long-term conflict with the central government; drug revenue is their primary source of funding. This presents a challenge for the implementation of any alternative development project: the Myanmar government cannot enter these areas, and international organizations must negotiate with armed groups to carry out work. Unless these armed groups obtain other sources of funding or political concessions, they have no incentive to abandon drug revenue.

Following the 2021 military coup, international aid was interrupted and the civil war intensified, further weakening the central government's control over border regions. Methamphetamine production in the Golden Triangle has surged, with prices plummeting to less than $1 per tablet, flooding Southeast Asian and Oceanian markets with cheap meth. Without a political solution, economic issues cannot even begin to be addressed.

The Limitations of Fair Trade

Some advocates have proposed the concept of "Fair Trade Coca," acknowledging the traditional uses of coca leaves and establishing a legal product market, hoping farmers can earn income through legal channels. This idea is theoretically attractive but faces numerous practical obstacles.

Legally, international law prohibits the international trade of coca leaves. The Single Convention on Narcotic Drugs of 1961 lists coca leaves as a controlled substance; changing this regulation would require international consensus among countries like the U.S. and Europe, which is nearly impossible. Commercially, market capacity is limited; the global market for coca tea and coca drinks is far from being able to absorb current coca production, and most coca would still flow into cocaine production. Bolivia tried this path; the Morales government promoted allowing traditional coca cultivation while cracking down on cocaine processing. The result was an expansion of coca cultivation areas and a subsequent increase in cocaine production. This shows that legalizing coca does not eliminate cocaine; as long as a market for cocaine exists, someone will process coca leaves into cocaine.

Roots on the Demand Side

All supply-side interventions cannot bypass the reality that demand still exists. As long as millions of people in the U.S. and Europe are willing to pay for cocaine, someone will grow coca to meet that demand. Eradicating a coca field or arresting a farmer will always lead to a new replacement stepping in. Supply-side intervention is, ultimately, a struggle against economic laws. When the profit margin of a commodity is as high as several thousand times, no amount of law enforcement can stop the supply. The true solution must start from the demand side, allowing supply to naturally wither by reducing demand.

This suggests that resources should be shifted from eradication and interdiction to prevention and treatment, addressing social issues such as poverty, despair, and mental health crises that lead people to seek drugs, and acknowledging the failure of the War on Drugs by trying different approaches. The $10 billion Plan Colombia did not reduce cocaine consumption by a single gram; if the same funds had been used for drug treatment and social services within the U.S., the results would have been vastly different.

No Simple Answers

There are no ready-made answers to the puzzle of alternative economies. Success requires the simultaneous presence of multiple conditions: an effective government, long-term commitment, sufficient funding, viable alternative crops, stable markets, and the trust of farmers—conditions that are rarely met at the same time. While failure is the norm and success the exception, this does not mean efforts should be abandoned. The examples of Turkey and Thailand prove that transformation is possible under the right conditions; the key lies in how to create those conditions.

The deeper question is whether governments are willing to invest the necessary resources. True alternative development requires decades of long-term investment and a commitment that spans political cycles, with the acknowledgment that there will be no victories to announce in the short term. This runs completely contrary to current political incentive mechanisms. Herbicide spraying can show results at a press conference, while building a rural economy cannot. As long as political incentives remain unchanged, alternative economies will remain nothing more than a slogan.

The dilemma of alternative economies is the ultimate manifestation of the War on Drugs thesis at the source of supply. Economic laws dictate that coca is difficult to replace; a tenfold income gap cannot be bridged by moralizing. Neuroscience locks in the rigid demand on the consumption end; the brains of millions of addicts in the U.S. and Europe will not stop craving cocaine just because an extra road was built in the Andes. Caught between these two forces, every eradication effort repeats the same script: destroy a coca field, and farmers move to more remote areas; strike a transport line, and smugglers develop more covert routes and more efficient synthetic alternatives. The $10 billion Plan Colombia brought not victory, but clear evidence of economic laws once again defeating legal ones.

The Post-Prohibition Era

In August 2015, Christina Smolke's team at Stanford University published a paper in Science: genetically modified yeast converted glucose into hydrocodone within 72 hours. No poppy fields required, no chemical plants, no cross-border smuggling networks. A device the size of a beer fermentation tank could, in theory, produce enough opioids to supply an entire city.

The significance of the experiment lies not in pharmacology, but in economics. The entire logic of the 55-year War on Drugs is built on one premise: restricting the flow of substances by controlling the supply chain. When the supply chain is shortened to the scale of a Petri dish, this premise no longer holds.

A trillion-dollar law enforcement system has been declared obsolete by a single test tube.

The Expiration Date of Prohibition

Before 1914, heroin was sold by Bayer as a cough suppressant, cocaine was an ingredient in Coca-Cola, and cannabis was available in pharmacies. The rise of prohibition was not the result of scientific discovery, but a product of political engineering: the passage of the Harrison Act was partly driven by racial fears linking opium to Chinese immigrants and cocaine to Black people. The 1961 Single Convention on Narcotic Drugs pushed prohibition globally; most signatories joined not because they faced drug problems, but due to diplomatic pressure from the United States.

Prohibition has carried an expiration date since its inception, and technology is accelerating its arrival.

The yeast synthesis by Smolke's team was just the beginning. AI-assisted drug design can already predict the relationship between molecular structure and pharmacological activity, speeding up the development of New Psychoactive Substances (NPS). In 2025, the DEA's list of identified new substances is updated quarterly, yet it still fails to keep pace with the innovation speed of underground laboratories. Nitazenes have been seized in all 50 U.S. states; they are 20 to 43 times more potent than fentanyl, and some variants are resistant to naloxone. The evolution of synthetic drugs is always faster than legislation.

When the threshold for synthesizing a new class of substances drops to a laptop and a gene-editing kit, border drug-sniffing dogs and X-ray machines become the Maginot Line: expensive, spectacular, and facing the wrong direction. Prohibition in the 1920s gave rise to Al Capone and was repealed 13 years later. The War on Drugs gave rise to El Chapo and the Sinaloa Cartel, and 55 years later, the machine is still running. The difference lies not in effectiveness (both created black market windfall profits), but in the consumer profile: alcohol was a consumer product for mainstream voters, while heroin is an anesthetic for marginalized groups. Policy survival depends not on effectiveness, but on who bears the cost.

The Scientific Counter-Offensive

Prohibition suppresses not only the circulation of substances but also the production of knowledge. When a substance is classified as Schedule I, the approval cycle for research permits lasts years, scientists take professional risks, and funding sources dry up. As a result, systematic research on psilocybin, MDMA, and LSD stagnated for nearly half a century. In 2010, British neuropsychopharmacologist David Nutt systematically ranked the harms of 20 psychoactive substances and found that the overall harm of alcohol ranked first, far exceeding heroin and cocaine; psilocybin and LSD were at the bottom, causing the least harm. The most dangerous substances are sold legally, while the safest are regulated at the same level as heroin. Nutt was consequently dismissed from his role as a drug advisor by the British government. Firing the person who provides the correct answer is the standard operation of a bureaucracy when faced with inconvenient truths.

The scientific community did not back down; psilocybin has received "Breakthrough Therapy" designation from the FDA, and ketamine has been approved for treatment-resistant depression. Although the FDA rejected the application for MDMA-assisted therapy for PTSD in 2024, it was merely a delay in the approval process rather than a reversal of scientific conclusions. The Psychedelic Renaissance is reshaping the boundaries of psychiatry. The psychedelic research centers at Johns Hopkins University and Imperial College London have received more funding in the past five years than in the previous half-century combined. Capital has smelled the opportunity: when a substance can both treat depression and bypass patent barriers, pharmaceutical companies' interest shifts from "compliance risk" to "market size."

The logic of this counter-offensive is strikingly similar to the experience of climate science: scientific consensus has long been established, but policy action lags by decades. The reason is the same obstacle: the gap between political short-sightedness and long-term evidence. It took 30 years for climate policy to move from the Kyoto Protocol to the Paris Agreement; the transition cycle for drug policy will not be shorter. The difference is that the consequences of climate change accumulate by the decade, while the 107,000 annual overdose deaths in the U.S. are immediate, countable bodies.

New Data from Policy Laboratories

The repeal of Oregon's Measure 110 and the re-criminalization of cannabis in Thailand are often cited as evidence of "failed reform." Such interpretations overlook a key variable: both failed due to implementation flaws, not conceptual errors.

In 2022, Thailand became the first country in Asia to legalize cannabis, with thousands of dispensaries appearing overnight on the streets of Bangkok. Three years later, in 2025, the Thai government announced the re-criminalization of cannabis. The reason was chaos caused by a lack of regulatory framework: cannabis was sold to minors, and the image of the tourism industry was damaged. Policies can swing back and forth; the "direction of history" is an illusion.

Meanwhile, Uruguay's state monopoly system for cannabis has operated for ten years; black market share has decreased, and youth usage rates have remained stable. Germany's 2024 legalization took a middle path, allowing home cultivation and non-profit clubs while banning commercial sales; first-year data shows a slight decrease in crime rates.

The pattern is clear: failed reforms lack supporting infrastructure, while successful reforms shift regulation from the criminal system to the public health system. Switzerland's prescription heroin program has run for thirty years without a new wave of addiction. These cases collectively point to the same conclusion: when policy goals shift from "eliminating drugs" to "managing risk," social costs decline.

The Endgame of Prohibition

A falsifiable prediction: by 2035, at least three G7 countries will implement medical legalization or decriminalization for a currently prohibited substance other than cannabis (most likely psilocybin). The driving force is not moral awakening, but fiscal pressure. The triple squeeze of incarceration costs, healthcare spending, and lost tax revenue will force politicians to make choices that prohibition supporters do not want to see. Cumulative tax revenue in legal U.S. cannabis states has reached $24.7 billion (as of 2023), money that previously flowed to cartels and street dealers. When fiscal deficits expand to a certain point, moral stances will give way to tax realities. Generational turnover will accelerate the process: Gallup 2024 data shows that over 70% of the 18-29 age group supports cannabis legalization, compared to less than 40% of those over 65. The voter base for prohibition is shrinking in a biological sense.

The end of the War on Drugs will not come in the form of a manifesto. No president will stand at a podium and announce, "The war is over, prohibition has failed." The end will be gradual, piecemeal, and full of reversals. Every local experiment accumulates evidence, and every failure corrects the path.

Fifty-five years ago, Nixon declared drugs "public enemy number one." Fifty-five years later, the public enemy remains, while the instigator of the war has long been in the ground. The only certain winners of this war are those who profit from the monopoly dividends created by prohibition: cartels, private prison companies, and every politician who wins an election on a "tough on crime" slogan.

The War on Drugs is a war where economics and neuroscience join forces to defeat the law. Every escalation in enforcement creates market space for the next generation of more lethal drugs: from opium to heroin, from OxyContin to fentanyl, from fentanyl to nitazenes. The evolution of the supply side is always faster than legislation, and the neural circuits of the demand side will not be rewired because of longer prison sentences. Fifty-five years of data have delivered the verdict: this war has no victory conditions.